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ABSTRACT OF THE DISSERTATION
Investigations into the Ulnar Response to Mechanical Stimuli Activating Lamellar and Woven
Bone Formation

by
Jennifer Ann McKenzie
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2009
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Woven and lamellar bone formation can be stimulated using mechanical loading. Woven bone
forms rapidly in response to damaging loading in a disorganized manner with low mineral density.
In contrast, lamellar bone formation can be induced in the absence of damage, and is
characterized by its slow, organized deposition and high density. In this dissertation, we first
examined the molecular response to woven and lamellar bone formation using damaging and
non-damaging dynamic loading protocols, respectively. We observed a significant increase in
gene expression related to angiogenesis, cell proliferation and osteogenesis prior to woven bone
formation, with significantly lower levels of expression associated with lamellar bone formation.
To fully characterize the molecular responses of woven and lamellar bone we used a whole
genome microarray. The micorarray results brought to light many inflammatory factors not
previously investigated in our model, expanded previous findings about angiogenesis, and
strengthened our understanding of the role of osteogenic pathways. Our investigations
suggested that angiogenesis is required for successful woven bone formation. We used several
angiogenic inhibitors, but were unable to prove the dependence of woven bone formation on
angiogenesis. Finally, we sought to separate the effects of static and dynamic strains on bone
formation. These findings demonstrate that in the absence dynamic strain, bone damage triggers
a woven bone response that leads to a functional repair of whole-bone strength. Overall, the work
done in this thesis has enhanced our understanding of bone formation. Future studies will
expand on the microarray findings and clarify the role of angiogenesis in woven bone formation.
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1.1

Introduction

Bone Fragility
All materials, including bone, are subject to failure if loaded to a force that exceeds the

materials ultimate strength. Skeletal fragility and osteoporosis are common in our nations aging
population and lead to an increased risk for hip, spine and wrist fracture (2000, Pramer 1999).
The link between vasculature and bone has emerged as critical to bone formation (Brandi 2006,
Fang 2005), and it has been hypothesized that vascular dysfunction may contribute to agerelated osteoporosis (Alagiakrishnan 2003, Burkhardt 1987). Novel interventions to enhance bone
mass could improve the quality of life and reduce mortality rates commonly associated with
skeletal fragility (Cooper 1997) and osteoporotic fractures. In order to accomplish this, it is
essential that we have a better understanding of the mechanisms that relate mechanical loading,
angiogenesis and new bone formation.

1.2

Ex Vivo and In Vivo Bone Fatigue/Creep
Bone fatigue is characterized by diminished mechanical properties after repeated loading

at a force well below the materials failure load. It causes loss of stiffness and strength and plays
an important role in stress fractures (Burr 1997, Jones 1989, Shaffer 2001, Sterling 1992). Both
the fatigue and creep behaviors of ex vivo compact bone have been well characterized (Carter
1985, Carter 1976, 1977, Pattin 1996). Bone exhibits three phases of fatigue (or creep) (Bowman
1994, Caler 1989, Carter 1977). The primary stage has an initial rapid increase in displacement
followed by a gradually decreasing slope. The secondary stage follows with a relatively constant
displacement rate. The tertiary stage begins with a rapid acceleration in displacement rate
leading to fracture. This reproducible change in displacement (and associated mechanical
property degradation) can be used as a functional assessment of damage level (Carter 1977,
Danova 2003, Pattin 1996, Uthgenannt 2007b). Not only is this behavior applicable to ex vivo
bone samples, in vivo bones behave in the same manner (Uthgenannt 2007b). Thus, through
monitoring the in vivo displacement of a bone we have the ability to control the level of imposed
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structural damage.

1.3

Strain and Fluid Flow Induced Using External Stimuli
Mechanical loading is required to maintain bone volume, as signaling cues trigger bone

formation. According to the mechanostat theory, interactions between bone modeling (by
osteoblasts forming bone) and bone remodeling (by osteoclasts resorbing bone) results in a net
equilibrium in bone, which acts to maintain the mechanical integrity of the bone (Frost 1982,
2000). Low magnitude bone strain (smaller than typical strains) will result in a state of disuse and
will cause a net loss of bone mass and strength, while high bone strain magnitudes (larger than
typical strains) will result in an increase of bone mass and strength. Strain magnitude and
location is highly correlated with changes in bone architecture (Frost 1982, Goodship 1979,
Lanyon 1979, Lanyon 1984, Rubin 1984, 1985, 1987, Smith 1996). Pathological overload
(supraphysiological strain magnitudes) results in microdamage or bone fracture. Fortunately, the
bone’s ability to adapt to the changes in the strain environment activates a repair process that
initiates bone formation to restore the structural integrity of the bone.
The complex mechanisms used to induce bone formation following mechanical loading are
not clearly defined. The level of bone strain is one of the determinants of bone formation. Loadinduced fluid flow may be an additional important factor in bone metabolism (Cowin 1995, Turner
1994a, Weinbaum 1994). It has been postulated that load-induced fluid flow contributes to the
movement of interstitial fluid through cortical bone tissue (Knothe Tate 2000a, Knothe Tate 1998,
Knothe Tate 2000b). This fluid movement may activate signaling cues (though application of
sheer stresses on the osteocytic cell processes) or enhance transport of cells and nutrients.

1.4

Bone Formation Response to Mechanical Loading
Studies have demonstrated formation of woven and lamellar bone in response to

mechanical loading as a result of supraphysiological (overload) or physiological (normal) strains
(Frost 1987a, Frost 1992, Hsieh 2002, Robling 2006a, Tami 2003). Woven bone is created in
areas of the bone where large amounts of damage have been inflicted. In this case, woven bone
forms rapidly to repair the structural competence of the damaged bone. In contrast, lamellar
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bone typically forms after mild overload (Frost 1987a, Frost 1992) and is characterized by the
organized manner in which new layers of bone are deposited. It has been hypothesized that
strain magnitude determines whether woven or lamellar bone forms (Frost 1987a, Frost 1992,
Hsieh 2001b, Turner 1994b). However, studies have disproved this notion by using lower,
physiological strains to induce woven bone formation (Rubin 1995). Consequently, strain
magnitude is not the only factor to distinguish between woven and lamellar bone formation.

1.5

Dynamic Loading
Dynamic loading has been widely used to stimulate bone formation. A forelimb loading

model, initially developed by Torrance et al. in 1994 has been used by many investigators as a
means to apply mechanical strain to the ulna (Figure 1.1). A strong benefit of this loading model
is that the points of applied load are far away from the region undergoing the greatest response
(Torrance 1994). This model has been used to characterize the bone response after multiple
(Hsieh 2001a, Mosley 2002, Mosley 1997, Robling 2001b), as well as a single bout bouts of
loading (Bentolila 1998, Kotha 2004, Lynch 2008, Matsuzaki 2007, Silva 2006a, Tami 2003,
Uthgenannt 2007a, Uthgenannt 2007b, Verborgt 2000, Wohl 2009).

3

Figure 1.1. Medial view of bones in a right forelimb of a rat during simulated loading (image
obtained by microCT). The majority of the load is transferred through the ulna (Kotha 2004), from
the flexed carpus to the olecranon process. The natural curvature of the ulna allows for bending,
which leads to increased strains on the medial side of the ulna near the midpoint. Image taken
from (Uthgenannt 2007b).

1.5.1

Damaging Loading
By applying cyclic compression (fatigue loading) to the rat forelimb, an ulnar stress

fracture can be created that triggers the two main tissue-level responses seen in humans –
intracortical resorption and periosteal woven bone formation (Hsieh 2002, Tami 2003). A single
bout of high strain fatigue loading has been used by our lab for a number of years. This model
can generate several distinct levels of fatigue damage (as defined by loss of stiffness)(Danova
2003, Uthgenannt 2007b), but my investigations have focused on a moderate damage level (65%
of the displacement to fracture; 2 Hz hsine, constant peak force). Damaging loading leads to a
loss of stiffness and ultimate force following the loading event. The structural properties are
restored within 2 weeks due to the rapid deposition of woven bone within the first 7 days, followed
by densification of the newly laid bone (Hsieh 2002, Uthgenannt 2007a). The damaging fatigue
loading model can be used to stimulate woven bone in a very controlled manner and is an
excellent research tool to help characterize woven bone formation.
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1.5.2

Non-damaging Loading
Dynamic loading that does not produce damage is a powerful stimulus for lamellar bone

formation. Loading protocols have been established that produce lamellar bone (Castillo 2006,
Forwood 1995, Robling 2000, Srinivasan 2003, Turner 1994b). Historically these loading
protocols involve multiple days of loading(Forwood 1995) or form lamellar bone only on the
endosteal surface of the bone while forming woven bone on the periosteal surface. Unlike other
multi-day models, in order to tease out the differences between woven and lamellar bone
formation, we wanted to only load the forelimbs only once. Not only would this ensure that the
stimulus for bone formation occurred only once, but complications arising from multiple rounds of
anesthesia, pain medication or loading stress would not complicate the healing response.
Examining the stimulation of lamellar bone in the absence of woven bone will help characterize
the mechanisms that separate these distinct two types of bone formation. In order to accomplish
this goal we needed to develop a single-bout non-damaging loading protocol to stimulate lamellar
but not woven bone formation. The non-damaging loading protocol should not compromise the
structural integrity of the bone following loading (which would presumably lead to woven bone
formation).

1.6

Static Loading
Creep loading, in contrast to fatigue, involves application of a static force. As with fatigue

loading, bone can sustain progressive displacement and damage under creep loading (Caler
1989, Carter 1985). Previous studies of the bone response to creep loading have reported mixed
findings. Positive osteogenic effects have been reported in dog femora (Meade 1984) and rabbit
calvariae (Hassler 1980) after long term continuous loading studies. However, the majority of
static loading has not shown the same osteogenic response as commonly seen in dynamic
loading. Comparisons between static versus dynamic loading protocols applied to the rabbit tibia
(Hert 1969), the turkey ulna (Lanyon 1984) and the rat ulna (Robling 2001b) demonstrated that
static loading produced no osteogenic response whereas dynamic loading was osteogenic. In
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growing rats, brief-duration static loading had an inhibitory effect on appositional bone formation
while dynamic loading triggered an adaptive formation response. While non-damaging static
loading is generally believed to be non-osteogenic (Lanyon 1984, Robling 2001b), to our
knowledge the response of bone to creep loading that produces measurable bone damage has
not been reported. Thus, we sought to develop a static creep loading model that could produce
bone damage without dynamic loading and thereby provide a useful experimental tool to separate
the effects of dynamic strain and damage.

1.7

Molecular Response to Loading
The molecular responses associated with mechanical stimulation of bone are not fully

understood, but some pathways are known and others are emerging (Armstrong 2007, Dean
2009, Dimitriou 2005, Glowacki 1998, Liedert 2006, Turner 2009, Wohl 2009). Mechanical
stimulation can lead to enhanced proliferation and differentiation of osteoblasts (Lau 2006) that
increase bone mass. Gene expression studies using quantitative reverse transcriptase
polymerase chain reaction (RT-PCR) have begun confirming physiological roles for many genes.
Murine tibial bending has been shown to upregulate bone formation genes, including bone
sialoprotein (Bsp) and osteocalcin (Osc)(Kesavan 2005). In the rat ulnar loading model,
upregulation of genes related to angiogenesis, cell proliferation and osteogenesis (including Bsp
and Osc) were found (Wohl 2009). In addition to qRT-PCR, microarrays have recently been used
to evaluate changes in gene expression from studies using mechanical loading. Four days of
tibial bending in mice led to differential expression of 346 genes compared to control, with
evidence for upregulation of angiogenesis and growth factor signaling (Xing 2005). Although
many gene expression studies have been completed, further studies are needed to clarify the
molecular responses to mechanically stimulated woven and lamellar bone formation.

1.8

Vascular Response to Loading
There has been strong evidence linking bone formation (osteogenesis) and blood vessel

formation (angiogenesis) (Brandi 2006, Matsuzaki 2007). Angiogenesis plays a role in skeletal

6

development (Gerber 1999, Pechak 1986) as well as fracture (Glowacki 1998, Hausman 2001)
and stress fracture healing (Matsuzaki 2007, Wohl 2009). In these situations, angiogenesis
precedes osteogenesis. In further support of the vascular response to loading, there is an
increase in 18F-fluoride uptake using positron emission tomography (PET) (Li 2005, Silva 2006a).
Fluoride uptake is influenced by factors that expose mineral surface or increase blood flow (Blau
1972, Genant 1974). These studies suggest a strong link between angiogenesis and
osteogenesis in the rat ulna following induction of a stress fracture. However, it has not been
shown that in the absence of angiogenesis bone does not form after mechanical loading.

1.9

Scope and Procedure of the Dissertation
In this dissertation, we studied the effects of dynamic and static loading on the rat ulna.

We used dynamic loading protocols that were damaging and non-damaging, leading to the
formation of woven and lamellar bone, respectively. We also used a damaging static loading
protocol to produce woven bone. First, we compared the molecular responses between
damaging and non-damaging dynamic loading. For this study, we created a non-damaging
loading protocol, a novel method for forelimb loading to stimulate lamellar bone formation in the
ulnar mid-diaphysis. We performed a comprehensive mechanical analysis of non-damaging
loading to ensure it caused no degradation of mechanical properties, did not stimulate woven
bone and led to an increase in lamellar bone formation. We compared the early molecular
responses of select genes between damaging and non-damaging loading (using quantitative real
time PCR). Following that study, we expanded our findings using a microarray. Next, we
investigated the importance of angiogenesis on woven and lamellar bone formation. Finally, we
examined the effects of static loading on rats in vivo. For this study, we compared and contrasted
two damaging loading protocols, in the absence and presence of dynamic strain.
In summary, we wanted to explore the molecular pathways associated with woven and
lamellar bone, thereby identifying the mechanical and molecular factors that promote bone
formation in the adult skeleton. Furthermore, we examined the link between angiogenesis and
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osteogenesis for both woven and lamellar bone formation. Lastly, we investigated the roles of
damage and dynamic strain on woven bone formation.
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2

Differences in Angiogenesis and Cell Proliferation Distinguish Woven and Lamellar

Bone Formation Following Mechanical Loading in the Rat Ulna
2.1

Abstract
Bone formation in the post natal skeleton can be induced using external mechanical

stimuli. Comparisons were made between the responses of bone to damaging and nondamaging loading, promoting the formation of woven and lamellar bone, respectively. Bone
formation was initiated using forelimb compression, a non-contact loading model. Damaging
fatigue loading of the rat forelimb stimulates formation of robust periosteal woven bone at sites of
ulnar damage. The objectives of our research were to develop a single-bout “lamellar” loading
protocol, enabling synchronization of the timelines for damaging and non-damaging loading
groups, and to study the gene expression changes caused by the stimulation of woven and
lamellar bone. We hypothesized that 1) lamellar bone is stimulated in a single loading bout
without creating bone damage, and 2) stimulation of woven bone formation (using damaging
loading) induces abundant over-expression of genes associated with cell proliferation,
angiogenesis and osteogenesis compared to stimulation of lamellar bone (using non-damaging
loading). Our study demonstrated that a single bout of loading could produce increased lamellar
bone formation in the absence of damage. Gene expression data gathered using quantitative
real time PCR and immunohistochemistry demonstrated increases in cell proliferation and
angiogenesis after damaging loading, but not for non-damaging loading. Damaging loading also
increased vascularity, whereas non-damaging loading did not change vascularity compared to
control. As time progressed, bone formation markers were higher in fold change for woven
(between 4 and 89-fold) than for lamellar bone (near 2-fold), consistent with the differences in
total bone volume formed ten days after loading. In summary, the early molecular changes in cell
proliferation and angiogenesis distinguish loading-induced woven from lamellar bone formation in
the adult skeleton.

2.2

Key terms
Woven bone, lamellar bone, gene expression, ulna, loading, angiogenesis
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2.3

Introduction
Osteogenesis occurs by formation of woven or lamellar bone. In the post natal skeleton,

woven bone forms under conditions that require rapid mineral deposition such as in distraction
osteogenesis, fracture healing and stress fracture repair (Jazrawi 1998, Johnson 1963, Mori S
2001, Tami 2003). Histologically, woven bone is characterized by relatively poor organization, low
mineral density and high cellularity (Mori S 2001). By contrast, lamellar bone forms at a slower
rate during normal skeletal growth and in response to mild anabolic stimuli. It is more highly
organized, denser and has fewer cells compared to woven bone. The underlying mechanisms
that trigger woven versus lamellar bone formation have been addressed by several authors
(Forwood 1994, Komori 2008, Maruyama 2007, Turner 1994b), but remain poorly understood.
Because in vivo mechanical loading can stimulate either woven or lamellar bone formation
(Turner 1994b), it provides an experimental approach to study the processes that lead to these
two distinct types of bone.
Mechanical loading that generates hyperphysiological bone strain and/or damage leads
to woven bone formation (Frost 1987b). Fatigue loading of the rat forelimb has been used to
generate bone damage resulting in an ulnar stress fracture. After a single bout of damaging
fatigue loading, there is a robust repair response characterized by periosteal woven bone
formation at the stress fracture site (Danova 2003, Tami 2003, Uthgenannt 2007b). Prior to
woven bone formation there is an increase in expression of genes related to cell proliferation,
angiogenesis and osteogenesis (Wohl 2009). Other models of woven bone formation have also
reported increased proliferation (Ai-Aql 2008, Wang 2003), vascularity (Carvalho 2004, Fang
2005, Gerstenfeld 2003b, Hausman 2001), and osteogenic gene expression (Ai-Aql 2008,
Gerstenfeld 2003a).
Mechanical loading that generates modest levels of bone strain without creating damage
can stimulate lamellar bone formation (Turner 1994b). The cell and molecular responses that
precede lamellar bone formation have not been extensively studied, although some work has
been done. Cell proliferation was increased three days after stimulation of endocortical lamellar
bone formation using tibial bending (Turner 1998). Increases in angiogenic and osteogenic gene
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expression were reported after four days of tibial bending in mice (Xing 2005). However, it was
not clear whether the loading protocol induced lamellar or a combination of woven and lamellar
bone formation, because tibial bending protocols often form lamellar bone only on the endosteal
surface, with woven bone on the periosteal surface (Akhter 1998, Robling 2000, Turner 1994b).
To better characterize the cell and molecular changes associated with lamellar bone formation
requires a loading protocol that does not induce woven bone formation. Forelimb compression
and tibial bending protocols that stimulate lamellar bone formation have been reported (Forwood
1995, Hsieh 2001b, Robling 2000, Srinivasan 2003), however these protocols typically involve
multiple days of loading. A limitation of multi day protocols for studies of gene expression is that
events triggered by the first bout of loading cannot be separated from events triggered by
subsequent bouts. To overcome this limitation, we wanted to develop a single-bout loading
protocol that stimulated a significant increase in lamellar bone formation in the rat ulna.
The first goal of our project was to establish a loading protocol to stimulate only lamellar
bone. The lamellar loading protocol needed to satisfy the following requirements: 1) loading in a
single bout, 2) non-damaging, 3) no woven bone formation as a result of loading, and 4) a
significant increase in lamellar bone formation on the loaded ulna compared to control. We
hypothesized that lamellar bone is stimulated in a single bout of non-damaging loading. Our
second goal was to compare the formation of lamellar bone induced by this protocol to the
formation of woven bone induced by the previously established damaging fatigue protocol
(Uthgenannt 2007a). We hypothesized that stimulation of woven bone formation (using
damaging loading) induces abundant over-expression of genes associated with cell proliferation,
angiogenesis and osteogenesis compared to stimulation of lamellar bone (using non-damaging
loading).

2.4

Methods
The right forelimbs of 155 adult male rats (F344, Harlan) age 4 ½ - 5 ½ mo (337.1 ± 21.9

g), were loaded in axial compression to stimulate woven or lamellar bone formation at the ulnar
mid-diaphysis (Tables 2.1 and 2.2). Contralateral left forelimbs served as non-loaded controls.
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With the animals anesthetized (1-3% isofluorane), right forelimbs were positioned in a loading
fixture connected to a servohydraulic materials testing machine (Instron 8841) and a 0.3 N
compressive pre-load applied. Rats designated for damaging loading (fatigue protocol) had the
right forelimbs cyclically loaded in a single bout (2 Hz, 18 N) to a total displacement of 1.3 mm
(avg. cycles 5279 ± 4544), a protocol shown to cause a 70% decrease in ulnar stiffness
(Uthgenannt 2007b) and to induce abundant woven bone formation (Uthgenannt 2007a). A
second loading protocol was used to stimulate lamellar bone formation as described below. After
loading the animals received analgesia (i.m., 0.05 mg/kg buprenorphine) and were returned to
their cages. All animals recovered well from anesthesia and mechanical loading. They were
allowed normal cage activity and ad libitum access to water and chow. Rats were euthanized by
carbon dioxide asphyxia at 1 hr (day 0), 1 day, 3 days, or 10 days after loading. Right and left
ulnae were dissected. This study was approved by our animal studies committee.

Table 2.1. Waveforms tested for use in a single-bout lamellar loading protocol. Woven bone
formation (day 10) was used as the primary exclusion criterion. Ultimately, a 15 N rest-inserted
(100 cycle) waveform was chosen based on low cycle number, low total displacement and
absence of woven bone formation.
Rest-inserted waveform (0.5 s loadunload followed by 9.5 sec rest)

Haversine waveform (2 Hz)
Number of
animals loaded

7

7

10

13

10

12

2

6

Peak loading
force (N)

14

15

16

17

18

15

15

18

Loading cycles

230

230

230

230

230

100

200

100

Total disp. (mm)

0.413
± 0.015

0.392
± 0.036

0.087
± 0.051

0.173
± 0.062

0.108
± .042

Loading-induced
woven bone
formation?

No
(0/7)

Yes
(5/10)

No
(0/12)

No
(0/2)

Yes
(2/6)

0.399
0.365
0.407
± 0.047 ± 0.028 ± 0.04
Yes
(1/7)

Yes
(2/10)

Yes
(3/13)
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Table 2.2. Forelimb loading parameters used for damaging (woven) and non-damaging (lamellar)
loading for gene expression, immunohistochemistry and vascular perfusion outcomes.
Gene Expression
Immunohistochemistry
Vascular Perfusion
Woven
Lamellar
Woven
Lamellar
Woven
Lamellar
Initial animal number
18
20
9
10
8
6
Final animal number
18
18
7
8
4
5
Applied force (N)
18
15
18.4 ± 0.7
15
18
15
Loading cycles
5279 ± 1071
100
8868 ± 8490
100
13,604 ± 7126
100
Displacement (mm)
1.30
0.10 ± 0.06
1.30
0.10 ± 0.06
1.30
0.18 ± 0.08

2.4.1

Development of a Single Bout Loading Protocol to Stimulate Lamellar Bone

Formation
In a preliminary experiment, we investigated two waveforms and a range of peak forces
from 14-18 N (1900-2400 microstrain) (Uthgenannt 2007b). Our goal was to determine a suitable
single-bout loading protocol that did not cause bone damage and stimulated only lamellar bone
formation (Table 2.1). The first waveform was a 2 Hz hsine, the same as used in damaging
loading. The second waveform was a rest-inserted trapezoid. In this waveform the load/unload
period is the same as in the fatigue waveform, but with a 9.5 second delay between loading
cycles. Five of the loading conditions were rejected because woven bone was observed on at
least one histological section. There were three loading protocols that did not result in woven
bone formation. The option using a 2 Hz hsine waveform (14 N) was rejected because the total
displacement was close to loading protocols that did stimulate woven bone formation. Of the two
remaining protocols, we chose a 100 cycle, 15 N rest-inserted waveform for further
characterization.
The right forelimbs of 29 rats were loaded in cyclic compression for a single bout of 100
cycles using the 15 N rest-inserted waveform. We assessed the effects of loading on mechanical
properties, bone damage and bone formation. Twelve rats were euthanized immediately after
loading for three-point bending tests (Instron 8841). Ulnae were positioned on supports 15 mm
apart and a displacement ramp (0.5 mm/s) was applied on the medial surface at the midpoint.
Structural properties were determined from force-displacement curves (Labview 7.0). Five
additional rats were euthanized immediately after loading to assess damage with basic fuchsin
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staining (Burr 1995). Briefly, upon dissection ulnae were placed into 10% formalin for 24 hours.
Bones were then subjected to graded fuchsin (80%, 90% and 100%) in a vacuum for 2 hr
intervals before being embedded in plastic. Forelimbs were sectioned 1 mm distal to the midpoint
(100 µm thick) and imaged using a confocal microscope (Carl Zeiss, LSM 510). Twelve rats were
euthanized on day 10 to measure bone formation using dynamic histomorphometry. Rats were
given intraperitoneal injections of calcein green (5 mg/kg, Sigma) on day 3 and alizarincomplexone (30 mg/kg, Sigma) on day 8 before being euthanized on day 10. Ulnae were then
embedded in methylmethacrylate (Sigma) using standard procedures. Sections (100 µm thick)
were cut 1 mm distal to the midpoint (D1) (Leica Microsystems, SP 1600). Each section was
mounted on a glass slide and imaged on a microscope (Olympus, DP-30) using fluorescein
isothiocyanate (Jacobsen) and tetramethylrhodamine isothiocynate (TRITC) filters for calcein and
alizarin, respectively. The sections were analyzed (Bioquant) for bone area, bone surface (BS),
mineralizing surface (MS), bone formation rate (BFR) and mineral apposition rate (MAR).

2.4.2

Gene Expression
Forelimbs were loaded using a single-bout protocol to stimulate woven or lamellar bone

formation (Table 2.2). Rats were euthanized on day 0 (1 hr), day 1 or day 3 for assessment of
ulnar gene expression using quantitative real time PCR (qRT-PCR) as described (Wohl 2009).
Both the loaded (right) and non-loaded control (left) ulnae were frozen in liquid nitrogen
immediately upon dissection. A central 5 mm piece of each ulna was pulverized, suspended in
trizol, and mixed with chloroform before separating the nucleic acid phase (phase lock gel tube,
Eppendorf). The total RNA was isolated using an RNeasy mini kit (Qiagen). RNA integrity was
quantified (Nanodrop, ND-1000) and verified (Agilent 2100 bioanalyzer). First strand cDNA was
synthesized (Superscript III, Invitrogen) from total RNA (500 ng). qRT-PCR reactions were carried
out at 20 μL total volume and measured with Power SYBR® green (7300 Real-Time PCR
System, Applied Biosystems). Samples were run in triplicate and the average was used for
further analysis. Primers were validated previously (Wohl 2009) or purchased as predesigned
sets (QuantiTect Primer Assays, Qiagen). Eleven target genes were evaluated including histone
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cluster 1, H4b (Hist4; marker for cell proliferation), cyclin D1 (Ccnd1; cell cycle protein); vascular
endothelial growth factor A (Vegf; angiogenic morphogen), hypoxia-inducible factor 1, alpha
subunit (Hif1a; hypoxia marker), platelet/endothelial cell adhesion molecule 1 (Pecam; endothelial
cell marker), bone morphogenetic protein 2 (Bmp2; osteogenesis-angiogenesis coupling factor),
bone sialoprotein (Bsp; matrix glycoprotein mediating cell adhesion), runt related transcription
factor 2 (Runx2; required for osteoblast differentiation), bone gamma-carboxyglutamate (gla)
protein (osteocalcin) (Bglap; marker for fully differentiated osteoblasts), osterix (Osx; required for
osteoblast formation), and patched homolog 1 (Ptch; marker of activated hedgehog pathway).
Data were analyzed using relative quantification ( 2

− ΔΔCT

) comparing loaded to non-loaded ulnae

by normalizing to glyseraldehyde-3-phosphate dehydrogenase (Gapdh).

2.4.3

Immunohistochemistry
BMP2, HIF1a and proliferating cell nuclear antigen (PCNA) proteins were localized using

immunohistochemistry. Following dissection, forelimbs (ulna and radius with some muscle tissue
left intact) were dissected, fixed overnight in 4% paraformaldehyde at room temperature and
decalcified in 14% EDTA. Specimens were embedded in paraffin and 5 µm sections were cut 1
mm distal to the midpoint. Primary antibodies for BMP2 (Santa Cruz, sc-6895) and HIF1a (Santa
Cruz, sc-22538) were diluted to 1:50 and 1:100, respectively. Sections were deparaffinized and
rehydrated then washed in dH20, treated with H202 (10 min). Antigen retrieval for BMP2 was
performed using a decloaking chamber (Biocare Medical, 95°C, 10 min) containing sodium citrate
buffer (pH 6.0). Antigen retrieval for HIF1a was performed in an oven (37 deg, 15 min) using 5%
pepsin. After antigen retrieval specimens were cooled and washed in PBS. Sections were
blocked with 10% of the appropriate serum (room temperature, 1 hr) and then incubated
overnight (4°C) with the optimized dilution of primary antibody. The next day, slides were washed,
incubated with a 1:400 dilution of streptavidin (Sigma), washed, incubated with 1:400 of the
appropriate secondary antibody, washed, then visualized using 3,3’-diaminobenzidine (DAB) for a
predetermined time. Slides were dehydrated, counterstained lightly with Mayer’s hematoxylin,
coverslipped, and examined under light field microscopy. PCNA immunohistochemistry was done
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according to the manufacturer’s protocol (Invitrogen). The antibody was visualized with DAB after
exposure for 5 minutes.

2.4.4

Vascular Perfusion
Vascular perfusion was performed as previously described (Matsuzaki 2007). Three

days after loading the rats were anesthetized by intraperitoneal injection of ketamine (87 mg/kg)
and xylazine (13 mg/kg). Heparin (10 mL, 100 USP units/mL) was injected (18-gauge catheter in
left ventricle) to inhibit clotting. The vasculature was irrigated with 100 mL saline and 60 mL of a
silicone rubber solution was injected (MICROFIL®, MV-122; Flow Tech). Following injection, the
specimens were stored at 4°C overnight to allow the rubber to cure. The forelimbs were
dissected and placed in 10% formalin overnight. MicroCT (uCT 40, Scanco Medical, 45 kV, 200
ms, 16 µm resolution) was used to image 1.6 mm of the central ulna starting 1 mm distal to the
midpoint and ending 0.4 mm proximal to the midpoint. The forelimbs were then decalcified in
14% EDTA for 3 weeks. Thin (5 µm) sections were cut 1 mm distal to the midpoint from paraffin
embedded blocks and mounted on glass slides. Slides were stained with hematoxylin and eosin
(H&E) before being analyzed for vessel number and area (Bioquant). A number of animals (n=4
for damaging loading and n=1 for non-damaging loading) were excluded from analysis due to
poor perfusion.

2.4.5

Statistics

Two-way analysis of variance (ANOVA) was used to compare across treatment groups and
timepoints. Differences between individual timepoints were assessed using Fisher’s protected
least significant difference test. Differences between right and left ulnae were assessed using
paired t-tests. Significance was defined at p<0.05.
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2.5

Results

2.5.1

A Single Bout of Loading Stimulates Increased Lamellar Bone Formation in the

Absence of Damage
We subjected forelimbs to a single bout of loading using a rest-inserted trapezoidal
waveform (0.5 s triangle load-unload to 15 N followed by 9.5 s rest; 100 cycles). Results indicate
that the loading protocol was non-damaging and stimulated lamellar bone formation. Three-point
bending tests demonstrated no significant differences in structural properties between loaded and
control ulnae (Table 3). There was no obvious difference in basic fuchsin staining between loaded
and control ulnae. In contrast, ulna loaded by a damaging fatigue protocol had diffuse staining,
indicating extensive damage (Figure 2.1). Dynamic histomorphometry revealed that ten days after
“non-damaging” loading, there was no woven bone observed on loaded or control specimens,
while lamellar bone formation was increased on loaded ulnae. Mineralized surface (MS/BS) was
increased by 50% in loaded ulnae vs. control, while MAR and BFR/BS were increased 24 and
92%, respectively (p<0.05) (Figure 2.1, Table 2.3). In summary, the rest-inserted trapezoidal
waveform (15 N, 100 cycles) satisfied all of the criteria for a non-damaging, single-bout induction
of lamellar bone formation.

Table 2.3. Mechanical property (day 0) and bone formation (day 10) outcomes from nondamaging loading (n=12/group). Non-damaging loading does not reduce mechanical properties
in the loaded ulna. Histological variables (mean ± SD) showed increased lamellar bone formation
after loading. Mineralizing surface per bone surface (MS/BS), bone formation rate per bone
surface (BFR/BS) and mineral apposition rate (MAR) were measured 1 mm distal to the midpoint
of the ulna. *p<0.05 vs. non-loaded

Non-loaded (Left ulna)
Loaded (Right ulna)

Ultimate
Force
(N)
12.9 ± 1.4
12.8 ± 0.9

Stiffness
(N/mm)
20.9 ± 3.0
20.2 ± 1.7

Energy to
Fracture
(N*mm)
22.7 ± 4.1
26.4 ± 5.2
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MS/BS
(%)

BFR/BS
(μm/day)

MAR
(μm/day)

47.3 ± 16.2
74.0* ± 11.7

0.68 ± 0.32
1.30* ± 0.30

1.41 ± 0.45
1.75* ± 0.20

Figure 2.1. Damaging loading (18 N hsine; 1.3 mm accumulated disp.) led to formation of woven
bone, while non-damaging loading (15 N rest-inserted waveform; 100 cycles) led to formation of
lamellar bone. Basic fuchsin staining on day 0 (immediately after loading) was used to assess
damage on bright field [inset] and fluorescent images. Damaging fatigue loading had high
amounts of diffuse ulnar staining while both non-damaging and non-loaded ulnae had no diffuse
damage. Bone formation (assessed by dynamic histomorphometry) 10 days after loading from
representative histological sections illustrate extensive woven bone formation after damaging
loading. There is increased labeled surface around the periosteum after non-damaging loading
compared to non-loaded control. A high powered view of double labeled surface on medial side of
ulnae demonstrate increased lamellar bone formation in non-damaging loaded compared to
controls. All sections were taken 1 mm distal to the midpoint (D1). (scale bar 500 micron unless
otherwise indicated)

2.5.2

Cell Proliferation is Upregulated Early After Damaging Loading, but Not for Non-

Damaging Loading
Cell proliferation marker Hist4 was upregulated 5- and 13-fold on days 1 and 3,
respectively, for damaging loading but was unchanged for non-damaging loading bone compared
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to controls (Table 2.4, Figure 2.2). Damaging loading also strongly upregulated the cell cycle
marker Ccnd1 (5- and 17-fold on days 1 and 3, respectively), whereas non-damaging loading led
to only a modest increase on day 3 (2-fold). Histologically, there was a clear periosteal
expansion seen on H&E stained sections on day 1 after damaging loading, but no qualitative
differences between controls and ulna loaded with the non-damaging protocol (Figure 2.2).
Consistent with qRT-PCR, PCNA staining was absent on sections from control and ulnae loaded
with the non-damaging protocol on days 1 and 3. In contrast, consistent with a recent report
(Wohl 2009), there was PCNA staining after damaging loading on the medial and lateral sides of
the ulna on days 1 and 3 (not shown).

Table 2.4. Fold change in gene expression (loaded/control) were greater for woven than for
lamellar bone formation. A fold change of 1 indicates no change from control. * p<0.05 vs.
control, a p<0.05 vs Day 0, b p<0.05 vs Day 1, # p<0.05 vs. lamellar

Gene Name
Histone H4
Cyclin D1

Gene
Symbol
Hist4
Ccnd1

Vascular endothelial
Vegf
growth factor
Hypoxia-inducible
factor 1, alpha
Hif1a
subunit
Platelet/endothelial
cell adhesion
Pecam
molecule 1
Bone morphogenetic
Bmp2
protein 2
Bone sialoprotein

Bsp

Runt related
Runx2
transcription factor 2
Osteocalcin

Bglap

Osterix

Osx

Patched homolog 1

Ptch

Damaging loading (woven bone)

Non-damaging loading (lamellar
bone)

Day 0 (1 hr)

Day 1

Day 3

Day 0 (1 hr)

Day 1

Day 3

0.87
± 0.46
1.37
± 0.39
1.69*#
± 0.26

5.69*a#
± 4.15
#
4.99*
± 1.51
3.03*a#
± 1.24

13.41*ab#
± 4.71
16.86*#ab
± 5.31
3.57*a#
± 0.50

0.98
± 0.33
1.42
± 0.57
1.08
± 0.14

1.06
± 0.65
1.69
± 1.28
1.15
± 0.22

0.75
± 0.35
1.86*
± 0.51
1.20*
± 0.11

1.60*
± 0.40

9.19*a#
± 3.14

15.18*ab#
± 3.83

1.23
± 0.30

1.26
± 0.44

1.44*
± 0.34

1.15
± 0.29

2.54*a#
± 0.54

4.73*ab#
± 0.88

1.14
± 0.29

1.15
± 0.36

1.58*ab
± 0.33

2.53*
± 0.46
1.16
± 0.25
1.03
± 0.31
0.99
± 0.31
#
0.5*
± 0.17
0.86
± 0.33

6.50*a#
± 4.03
13.57*#
± 4.92
2.55*#
± 0.78
0.39*#
± 0.10
3.81*#
± 2.03
1.97*
± 0.97

6.98*a#
± 2.49
88.98*#ab
± 28.84
8.18*ab#
± 2.57
3.85*ab#
± 1.09
24.01*ab#
± 9.53
6.65*ab#
± 2.92

1.94*
± 0.51
1.10
± 0.38
1.05
± 0.42
1.03
± 0.42
1.00
± 0.35
0.94
± 0.32

1.70
± 0.84
1.57
± 0.74
1.31
± 0.51
1.43
± 0.67
1.61
± 0.76
1.46
± 0.69

1.90*
± 0.44
1.93*a
± 0.31
1.61*a
± 0.35
2.24*ab
± 0.64
2.14*a
± 0.45
1.56*a
± 0.30
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Figure 2.2. Damaging loading (stimulating woven bone) led to periosteal expansion and
increased cell proliferation on day 1, while non-damaging loading (stimulating lamellar bone) was
unchanged from control. Hematoxylin and eosin (H&E) staining of sections demonstrate cortical
bone cracks [inset] following damaging loading. Damaging loading increased expression of cell
proliferation markers compared to non-damaging loading and control. Gene expression for Hist4
and Ccnd1 (qRT-PCR) demonstrate a significant increase (loaded/non-loaded) on days 1 and 3
only in the ulnae stimulated to produce woven bone. There was no increase in Hist4 after nondamaging loading at any timepoint. All histological sections are taken 1 mm distal to the midpoint
(scale bar 50 µm). b–original cortical bone; p-periosteum; m-muscle; ap<0.05 vs Day 0; bp<0.05
vs. Day 1; * p<0.05 Loaded vs. non-loaded; #p<0.05 Non-damaging vs damaging loading

2.5.3

Early Angiogenesis Distinguishes Damaging from Non-Damaging Loading
Expression of Vegf and Hif1a were upregulated 1.6 fold one hour after damaging loading

(Table 2.4), indicating an early angiogenic stimulus. Expression of Hif1a increased to 9- and 15fold on days 1 and 3 after damaging loading, whereas non-damaging loading led to a small but
significant increase on day 3 (1.4-fold). Damaging loading upregulated Vegf and Pecam
expression on days 1 and 3 (between 3- and 5-fold) while non-damaging loading only increased
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expression on day 3 (less than 1.6-fold). Consistent with RT-PCR, histological staining of HIF1a
was increased in ulnar sections after damaging loading, but not after non-damaging loading on
days 1 (Figure 2.3) and 3 (not shown). Bone morphogenetic protein 2 (Bmp2), known as an
osteogenic-angiogenic coupling factor (Wozney 1998), was upregulated at all timepoints after
both types of loading (between 2- and 7-fold), with the exception of non-damaging loading at day
1 (1.7 fold, p=0.11). The fold changes were consistently near 2-fold following non-damaging
loading and 6-fold (days 1 and 3) after damaging loading (p<0.05). Immunohistochemistry for
BMP2 showed protein localized to some periosteal lining cells as well as the interior lining (intima)
of most blood vessels (Figure 2.3), consistent with a previous report (Wohl 2009). Results for
BMP2 on day 3 were similar to day 1 (not shown).

Figure 2.3. Immunohistochemistry staining at day 1 show increased localized protein expression
of BMP2 and HIF1a following stimulation of woven compared to lamellar bone formation. Both
loading protocols increased BMP2 staining on day 1 in a small number of lining cells (thin arrow),
as well as neuro-vascular bundles (arrowhead). There was additional staining in connective
tissue and blood vessels were outlined both in the periosteum (block arrow) and muscle (not
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shown) after damaging loading. HIF-1a staining is present in small amounts after non-damaging
loading, and is much more prominent in neutrophils after damaging loading (black arrow).
Staining for BMP2 and HIF1a is absent in the negative control (damage-loaded ulna, no primary
antibody). Gene expression (qRT-PCR) confirms a significant increase in the loaded limb at
nearly all timepoints for Bmp2, regardless of loading group. Vegf is upregulated one hour after
loading (day 0) for woven bone formation and the upregulation is sustained through day 3. Hif-1a
is upregulated on days 1 and 3 for woven bone, over 10-fold higher than lamellar bone at day 3.
All sections are taken 1 mm distal to the midpoint. b–original cortical bone, p-periosteum ; scale
bar 50 microns. Legend for gene expression plots is shown in Figure 2.2.

Woven bone formation increased vascularity assessed using perfusion followed by
microCT and histological analysis on day 3 (Figure 2.4). The vessel number, area and volume
were all increased significantly when comparing damaging to non-damaging loading, with no
differences between non-damaging loading and control.
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Figure 2.4. Vascularity increased in response to damaging loading. The vascular response was
assed using histological sections (stained with H&E) and microCT imaging. H&E stained sections
for control and lamellar bone formation are qualitatively different from sections where woven bone
formation is occurring (vessels are black dots). Similarly on microCT the appearance of blood
vessels is increased after damaging loading. Quantitatively, there is an increase in the number,
area and volume of vessels associated with woven bone formation when calculating a percentage
change between loaded and control. There is no difference in vessel number, area or volume
between ulnae loaded with the non-damaging protocol and controls. (n=4-5/group; scale bar 500
micron)

2.5.4

Genes Associated with Osteogenesis are Highly Upregulated on Days 1 and 3 After

Damaging Loading and Only Moderately Upregulated on Day 3 After Non-Damaging
Loading
Expression of Osx was reduced 2-fold one hour after damaging loading, but upregulated
3.8- and 24-fold by days 1 and 3, respectively (Figure 2.5). Damaging loading also upregulated
Runx2 expression (3- and 8-fold on days 1 and 3, respectively). Furthermore, Bglap was
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upregulated 4-fold on day 3. In addition, damaging loading upregulated Bsp expression 14- and
89-fold on days 1 and 3. The fold changes for osteogenic gene expression markers were
significantly higher as a result of damaging loading (compared to non-damaging loading).
Nevertheless, gene expression was significantly upregulated when comparing non-damaging
loading to control ulnae (between 1.6 and 2.5-fold increase) on day 3. With regard to bone
development, the hedgehog pathway was activated as evidenced by increased Ptch expression
on day 3 for both damaging and non-damaging loading (7- and 1.5-fold, respectively). On day 3
formation of new bone was evident on histological images (Figure 2.1).

Figure 2.5. Gene expression of osteogenic markers show increased expression at days 1 and 3
for woven bone, with a significant increase at day 3 for lamellar bone. The changes for woven
bone were 5 and 11 times larger than lamellar bone at day 3 for Runx2 and Osx, respectively.
The upregulation in Bsp was over 8 and 45 times larger than lamellar bone on days 1 and 3,
respectively. Legend for gene expression plots is shown in Figure 2.2.
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2.6

Discussion
The objectives of our research were to establish a loading protocol to stimulate only

lamellar bone, and compare the processes associated with lamellar and woven bone formation.
In support of our first hypothesis, lamellar bone formation was stimulated by a single bout of nondamaging loading. The single-bout loading protocol did not induce woven bone formation,
stimulated a significant increase in bone formation of the loaded ulna, and did not produce
structural damage. In support of our second hypothesis there were dramatic differences in gene
expression levels between loading protocols that produced woven and lamellar bone. In
particular, upregulation of angiogenic genes Vegf and Hif1a was seen on all days for woven
bone, but only a modest upregulation was reported on day 3 for lamellar bone. In addition, vessel
number, area and volume were all significantly increased following damaging loading, but not
after non-damaging loading. Taken together, these results indicate the importance of vascular
support for woven, but not for lamellar bone formation.
Induction of lamellar bone formation in the rat skeleton by mechanical loading has been
documented previously, although most studies have used multi-day loading protocols (Chen
2008, Hsieh 2001b, Robling 2001a, Turner 1994b). For the purposes of our study, we needed a
one-day protocol because we wanted to document effects relative to a single time-zero, rather
than additive effects of multiple days as has been described previously (Kesavan 2005, Xing
2005). There is one report describing endortical lamellar bone formation in the rat tibia after a
single bout of loading, although that report also described woven bone periosteally (Forwood
1994).For the purposes of our study, we needed to use a single-day loading protocol, with no
woven bone formation. It is not clear if the protocols from previous studies satisfied these criteria.
To our knowledge, a single-day loading protocol stimulating lamellar bone formation has not been
developed in the rat ulna. A single loading session also minimizes the number of procedures the
animal is subjected to; including loading, anesthesia and injections. The development of a single
day loading protocol has allowed for synchronization of bone formation timelines between woven
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and lamellar bone, to further characterize the mechanisms associated with these two types of
bone.
Cellular proliferation is increased following mechanically induced stress fractures (Wohl
2009) and in fracture repair (Heiner 2006, Rundle 2006). Our study also saw a large increase
cellular proliferation prior to woven bone formation, as early as one day after loading. Three days
after loading there is a 17-fold upregulation of cell cycle marker Ccnd1. In contrast, there was
only a slight increase in lamellar cell proliferation on day 3. Only Ccnd1 was upregulated with a
relatively moderate fold change of 1.7 above non-loaded control at day 3. Similar to our lamellar
results, one study reported an increase in osteoblast proliferation three days after tibial bending
(Turner 1998). In their study, lamellar bone was formed on the endosteal surface of the tibia,
while perosteal bone formation was not analyzed. Taken together, these two studies indicate that
an early increase cell proliferation is not necessary for formation of lamellar bone. This may
indicate that active osteoblasts are able to form lamellar bone without additional proliferation of
new osteoblasts.
The role of angiogenesis has been documented in skeletal development (Colnot 2001,
Ferrara 2001, Pechak 1986), fracture repair (Glowacki 1998, Hausman 2001, Street 2002), and
distraction osteogenesis (DO) (Fang 2005, Jazrawi 1998). Fracture studies have shown the
importance of angiogenesis for bone formation (Pacicca 2003) by inhibiting vessels using small
molecules or a drug (TNP 470). Additionally, DO has been shown to be dependent on both
VEGFR1 and VEGFR2 signaling (Jacobsen 2008). These studies demonstrate the importance
of angiogenesis in a healing setting where large amounts of bone are required to help stabilize
the injury. A stress fracture healing response is characterized by rapid, non-endochondral woven
bone formation (Uthgenannt 2007a), which makes it different than fracture healing and DO that
include intramembraneous and endochondral bone formation (Einhorn 1998, Gerstenfeld 2003a).
Thus, using a fracture repair or DO model, it is difficult to isolate woven bone formation from other
processes occurring at the site of new bone formation. In stress fracture repair, the spatial
pattern of vascular changes matched the subsequent pattern of woven bone formation
(Matsuzaki 2007), suggesting that the vasculature was a template for bone formation. Our study
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showed an early angiogenic gene expression response to damaging loading, and an increase in
vascularity at day 3. In sharp contrast, we did not detect an increase in vascularity for lamellar
bone formation. Lamellar bone formation induced by treadmill running in young rats did lead to
increase in Vegf expression, vascularity and bone formation in the tibia after several weeks of
training (Yao 2004). This study is not consistent with our results, but they used younger rats (9
weeks old) and analyzed bone formation in the trabecular compartment, which differs from the
periosteal lamellar bone formation we were investigating in adult rats (19-24 weeks old).
Increased expression of Bmp2 was seen in response to both damaging and nondamaging loading. This supports the finding that Bmp2 is mechanresponsive (Sato 1999). The
early upregulation seen after damaging loading is consistent with previous findings from stress
fractures (Wohl 2009) and fracture repair (Cho 2002, Tsuji 2006). Unexpectedly, our results also
demonstrated a significant increase (near 2-fold) in Bmp2 after non-damaging loading. Bmp2 has
been shown to stimulate angiogenesis by upregulation and secretion of Vegf by osteoblasts
(Deckers 2002). This is consistent with our woven bone results, but not with our results for
lamellar bone formation. Loading-induced Bmp2 expression is three-times larger following
damaging loading (compared to non-damaging loading) and supports an osteogenic-angiogenic
coupling for woven bone formation with increased Vegf expression at all timepoints. Nondamaging loading led to an increase in Bmp2 associated with osteogenesis, but did not activate
angiogenic coupling, as there was no coordinated increase in Vegf expression.
The upregulation of bone formation genes seen in our study are similar to other studies.
Murine tibial bending studies induced upregulation of bone formation genes (Kesavan 2005, Lau
2006), consistent with our result that bone sialoprotein and osteocalcin were upregulated by day
3 after damaging and non-damaging loading. Although the bone formation was not detailed, tibial
bending likely produced endosteal lamellar and periosteal woven bone formation. In our study,
separation of woven and lamellar bone demonstrated that the gene expression responses were
different in magnitude. There were larger fold changes associated with woven bone formation,
and the upregulation of these genes happened earlier. Our results showed upregulation of 10
genes on day 1 for woven bone formation (fold changes ranging between 2 and 13.5), in contrast
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to lamellar bone, which did not have any significant increases at day 1. Moreover, by day 3 we
are able to see a large upregulation of osteogenic genes for woven (4- to 89-fold increase)
compared to lamellar (1.5- to 2.25 fold increase) bone formation.
One of the strengths of our study was the synchronization of the timelines for induction of
woven and lamellar bone formation. The development of a single-bout lamellar loading protocol
ensured that only one loading event occurred before the tissue was extracted for analysis. In
addition, the damaging and non-damaging loading protocols lead to the formation of two distinct
types of bone formation, woven and lamellar. Having the ability to separate the bone formation
responses using different initial loading protocols allowed us to compare and contrast the gene
expression and vascular responses of woven and lamellar bone.
There were a few limitations to our study. First, only three discrete early timepoints (1 hr,
1 day and 3 days after loading) were evaluated based on previous studies that showed early
changes in gene expression and vascularity following damaging fatigue loading (Matsuzaki 2007,
Silva 2006b, Wohl 2009). Second, although our data suggests that woven bone is dependent on
angiogenesis, we have yet to prove that in the absence of angiogenesis, woven bone is inhibited.
Finally, one consideration in our damaging loading scenario is the accumulation of lamellar bone
adjacent to woven bone formation. In an attempt to reduce the amount of lamellar bone
formation in the samples evaluated after damaging loading we confined our gene expression
region of interest to 5 mm near the site of stress fracture formation, an area shown to produce
predominantly woven bone (Uthgenannt 2007a). Furthermore, woven bone was absent in our
lamellar bone protocol. This ensured that any differences in gene expression observed were
from the formation of woven bone in our damaging loading model.
In conclusion, lamellar bone formation can be initiated using a single, non-damaging bout
of loading in the rat ulna. We showed dramatic differences in gene expression levels between
loading protocols that stimulated woven and lamellar bone formation. Damaging loading
increased expression of genes related to cell proliferation and angiogenesis while increasing
vascularity at day 3. In addition, there were considerable fold-increases in osteogenic gene
expression, and this upregulation is consistent with the large amount of woven bone formation
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observed histologically on day 10. Non-damaging loading did not increase upregulation of cell
proliferation or angiogenic gene expression at early timepoints, and did not result in an increase
in vascularity. There was a modest upregulation of osteogenic gene expression at day 3 that is
consistent with the amount of lamellar bone formation seen histologically. In summary, the cell
proliferation and angiogenic responses at the molecular level distinguish loading-induced woven
from lamellar bone formation in the adult skeleton.
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3

Differential gene expression from microarray analysis distinguishes woven and

lamellar bone formation in the rat ulna following mechanical loading

3.1

Abstract
Formation of woven and lamellar bone in the adult skeleton can be induced through

mechanical loading. Although much is known about the morphological appearance and structural
properties of the newly formed bone, the molecular responses are still not well understood.
Recent studies have made use of microarrays to help characterize the molecular responses to
loading. The objective of our study was to distinguish the molecular responses between woven
and lamellar bone formation using a microarray. Rat forelimb loading was completed in a single
bout. Woven bone was induced using a damaging fatigue loading protocol. In contrast, lamellar
bone was induced using a non-damaging loading protocol. Microarrays were performed at three
timepoints after loading: 1 hr, 1 day and 3 days. Microarray results were analyzed using two
commercial software packages, Partek and GeneGo. Confirmation of microarray results was
done for a select group of genes using quantitative real-time PCR. There were a higher number
of differentially regulated genes for woven compared to lamellar bone formation. A total of 395
genes were differentially expressed between formation of woven and lamellar bone 1 hr after
loading, while 5883 and 5974 genes were differentially expressed on days 1 and 3, respectively.
Microarray data demonstrated increased expression of many inflammation factors 1 hr after
loading. Specifically, interleukin-6 (Il6) was upregulated over 500-fold (by qRT-PCR) after
damaging loading, but was not differentially regulated after non-damaging loading compared to
control. There was evidence of vasodilation, with increased expression of prostaglandindendoperoxide synthase 2 (Ptgs2/Cox2) at all timepoints for woven bone (8- to 16-fold
upregulation by qRT-PCR). Bone formation markers were also expressed. For example,
sclerostin (encoded by the Sost gene), which inhibits bone formation, was downregulated at all
timepoints for woven bone (almost 20-fold on day 1). Moreover, Sost expression was nearly
significantly downregulated following non-damaging loading on day 1 (1.6-fold; p=0.055). The
micorarray results brought to light many inflammatory factors in our model, expanded our
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previous findings about angiogenesis, and strengthened our understanding of the role of
osteogenic pathways.

3.2

Key Terms
Mechanical loading, microarray, rat, woven bone, lamellar bone, angiogenesis

3.3

Introduction
Mechanical loading can induce woven or lamellar bone formation at the histological level.

Woven bone is characterized by its rapid deposition, disorganization and low density. In contrast,
lamellar bone deposits more slowly, is more organized and has a higher bone mineral density.
Rat forelimb loading can be performed in a single bout to induce the formation of woven bone
using damaging fatigue loading (Bentolila 1998, Tami 2003, Uthgenannt 2007a), or lamellar bone
using a non-damaging loading protocol (McKenzie 2009). Although many structural and
mechanical aspects between woven and lamellar bone are well described, the molecular
mechanisms associated with these two bone formation processes are not fully understood. A
better understanding of these molecular events could be the basis for future developments of
novel therapeutics to accelerate bone formation.
Previous studies investigating damaging loading in the rat ulna found early increases in
cell proliferation (Wohl 2009) and angiogenesis (Matsuzaki 2007, Wohl 2009) prior to woven bone
formation. A follow up study found that lamellar bone formation did not increase cell proliferation,
vessel volume or expression of angiogenic genes at early timepoints (McKenzie 2009). However,
these studies only examined select target genes related to angiogenesis, cell proliferation and
osteogenesis. Thus, further study is required to broaden our understanding of the overall
expression differences between woven and lamellar bone formation.
A microarray allows simultaneous measurement of the expression values in thousands of
genes (Trevino 2007). A more traditional analysis of selecting a limited number of genes using
quantitative PCR cannot study thousands of coordinately expressed genes in a timely manner.
Therefore, expression profiling is an efficient experiment that can reveal previously unrecognized
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roles for genes. A whole genome analysis of gene expression can help us to understand the
complex process of bone formation.
The objective of our study was to identify gene expression differences between woven
and lamellar bone formation using a whole genome microarray. We first induced woven and
lamellar bone formation using mechanical loading of the rat forelimb. Damaging fatigue loading
resulted in an ulnar stress fracture and subsequent healing through the formation of woven bone.
A rest-inserted non-damaging loading protocol induced the formation of lamellar bone in the ulna.
We set out to expand our current knowledge about the similarities and differences between
woven and lamellar bone formation through the exploration of microarray data.

3.4

Methods

3.4.1

Forelimb Loading
The right forelimbs of 42 anesthetized adult male rats (5 mo., 337 ± 24 g) were loaded in

axial compression (Table 3.1). Rats were anesthetized (1-3% isoflourane) prior to loading. The
forelimb was positioned between two loading fixtures on a servohydraulic testing machine
(Instron 1331) and a 0.3 N compressive preload was applied. Rats designated for damaging
fatigue loading had the right forelimbs cyclically loaded in a single bout (2 Hz, 18 N) to a 1.3 mm
increase in displacement (avg. cycles 7501 ± 5676), a protocol shown to cause a 70% decrease
in ulnar stiffness (Uthgenannt 2007b) and to induce abundant woven bone formation (Uthgenannt
2007a). Rats designated for non-damaging loading had the right forelimbs loaded using a
trapezoidal waveform (0.5 s triangle load-unload to 15 N followed by 9.5 s rest; 100 cycles), a
protocol which does not induce any bone damage, but significantly increases lamellar bone
formation (McKenzie 2009). After loading, rats received analgesia (i.m. 0.05 mg/kg
buprenorphine) and were allowed normal cage activity and ad libitum access to food and water.
Rats were euthanized at 1 hr, 1 or 3 days after loading corresponding to timepoints that were
previously investigated (McKenzie 2009, Wohl 2009). An additional six age-matched rats served
as normal controls and were not loaded. This study was approved by the Washington University
Animal Studies Committee.
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Table 3.1. Summary of the number of rats loaded for each timepoint. The loading parameters for
stimulation of woven and lamellar bone formation differed.
Non
loaded
Woven
Lamellar
Normal

3.4.2

Num. of rats loaded
1 hr
Day 1 Day 3
7
7
7
7
7
7

Increase in disp.
Applied
Loading cycles
(mm)
force (N)
18
7501 ± 5676
1.3
15
100
0.099 ± 0.062

6

RNA Extraction and Preparation
Immediately upon dissection the right ulna was frozen in liquid nitrogen, and recently

described RNA extraction methods were followed (Wohl 2009). A 5 mm piece of the central ulna
was pulverized and suspended in trizol. Total RNA was isolated using an RNeasy mini kit
(Qiagen) and quantified (Nanodrop, ND-1000). RNA from each rat (48 rats total) was run on a
microarray by the Washington University Genome Sequencing center (Illumina, RatRef-12; 48
arrays total). The total RNA quality was determined by Agilent 2100 bioanalyzer (Agilent
Technologies) according to manufacturer’s recommendations. At the Genome Sequencing
center, RNA transcripts were amplified by T7 linear amplification (MessageAmp TotalPrep
amplification kit; ABI-Ambion). 400 ng of each total cellular RNA sample (11 μl) was mixed with
an oligo-dT T7 primer (1 μl), 10x reaction buffer (2 μl), dNTP mix (4 μl), Rnase Inhibitor (1 μl), and
Arrayscript RT enzyme (1 μl). Reverse transcription was carried out for 2 hours at 42 ºC. After a
three minute incubation on ice, the cDNA underwent second strand synthesis by adding water (63
μl), 10x second strand buffer (10 μl), dNTP mix (4 μl), DNA polymerase (2 μl) and Rnase H (1 μl).
This cocktail was incubated at 16 ºC for 2 hours. Following a column cleanup using DNA
columns provided in the MessageAmp TotalPrep kit, in vitro-transcription was carried out by
adding 10x T7 reaction buffer (2.5 μl), T7 biotin-NTP mix (2.5 μl), and T7 RNA polymerase
enzyme mix (2.5 μl) and incubated at 37 ºC. The IVT reaction was carried out for 14 hours.
Following reaction termination with water (75 μl), the amplified RNAs (Li) were cleaned with RNA
columns provided in the MessageAmp TotalPrep kit. The aRNAs were quantitated on a
spectrophotometer and quality determined by Agilent 2100 bioanalyzer (Agilent Technologies)
according to manufacturer’s recommendations.
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3.4.3

Microarray Hybridization, Detection and Analysis
750 µg of each aRNA in water (5 µl) was suspended in Illumina “HYB” buffer (10 μl) and

heated to 65 ºC for five minutes, then allowed to cool to room temperature. The samples were
applied to RatRef-12 Expression BeadChips and hybridized at 58 ºC for 16-20 hours at high
humidity. Arrays were washed according to Illumina standard protocol. Immobilized, biotinylated
aRNAs were then detected by staining with cy3 Streptavidin (1 μg cy3-SA per 1 ml of Illumina
“Block E1”) for 10 minutes at room temperature. Arrays were washed and dried according to
Illumina standard protocol, then scanned on an Illumina BeadArray Reader. Laser power and
PMT voltage were kept constant for cy3 scans. After image quantitation (Illumina Beadscan, v3)
data were imported into Beadstudio software. On-slide spot replicates were averaged by
Beadstudio and individual spot data were reported.

3.4.4

Microarray Analysis Using Partek Genomics Suite
Quantile normalized microarray data was retrieved from the Washington University

Genome Sequencing Center and imported into Partek Genomics Suite (Partek Incorporated, 6.4).
First, data were filtered to include only data points which had a detection p-value less than 0.01 in
all microarrays. This excluded data points which were not significantly different from the
background of the chip. Next, the average signal data were log transformed. Principal
component analysis revealed one outlier in the day 3 lamellar group. This sample was excluded
from all further analysis. Using the Partek “gene expression workflow” to detect differentially
expressed genes, an ANOVA was performed. ANOVA factors included sentrix position, chip
number, treatment, timepoint, and all contrasts between treatment and timepoint. Next, to
determine if expression of a gene was significantly different between the two loading conditions
we used a false discovery rate (FDR) of 0.05 in a step up analysis. From this analysis, gene lists
were created comparing each treatment group and timepoints for a total of 9 comparisons (i.e.
lamellar day 1 vs. normal; woven day 3 vs. lamellar day 3). Exported files included significant
genes, fold changes and p-values for comparisons between groups and timepoints. These lists
were then imported into GeneGo for further analysis.
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3.4.5

Data Mining Using GeneGo
The files where uploaded into GeneGo (version 5.4) by accession number. A workflow for

each comparison (i.e. lamellar 1 hr over normal) was generated using GeneGo’s “Analyze Single
Experiment” feature with thresholds of 0.99 and 0.0001 for p-value and fold change, respectively.
Non-stringent filters were used in this step as all non-significant expression changes had been
excluded by Partek analysis. The top ten “Statistically Significant Maps” from each workflow, as
well as canonical GeneGo Pathway Maps (associated with angiogenesis, bone development,
inflammatory response, hypoxia response etc.) were investigated. In addition, relevant pathways
presented in the surveyed literature were examined for genes or pathways of interest, i.e genes
with expression changes above 2-fold or with unique temporal patterns, or several genes in a
single pathway being differentially regulated.

3.4.7

Quantitative Real-Time PCR
Following microarray analysis, quantitative real-time PCR (qRT-PCR) was used to

validate expression patterns for select genes including interleukin-6 (Il6; a pro-inflammatory
cytokine), nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (Nfkb1; a
transcription factor), nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,
alpha (Nfkbia; an NF-kb inhibitor), toll-like receptor 2 (Tlr2; a cell surface receptor implicated in
mechanotrandsuction and inflammation), selectin, endothelial cell (Sele; a cell adhesion
molecule), prostaglandin-endoperoxide synthase 2 (Ptgs2, also known as Cox-2; a possible
indicator of vasodilation and/or mechanotransduction), chemokine (C-X-C motif) ligand 10
(Cxcl10; an angiostatic factor), sclerostin (Sost; an inhibitor of the Wnt pathway), matrix
metalloproteinase 13 (Mmp13; a proteinase capable of cleaving collagen), and cathepsin K (Ctsk;
a protease involved in bone remodeling). First strand cDNA was synthesized (Superscript III,
Invitrogen) from total RNA (500 ng). qRT-PCR reactions were carried out at 20 μL total volume
and measured with Power SYBR® green (7300 Real-Time PCR System, Applied Biosystems). All
primers were purchased as pre-validated sets from Qiagen (QuantiTect Primer Assays; Table
3.4). Samples were run in triplicate and the average was used for further analysis. Data were
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−ΔC T

analyzed using relative quantification ( 2

), where gene CT values were normalized to

glyseraldehyde-3-phosphate dehydrogenase (Gapdh).

3.5

Results

3.5.1

Allocation of Differentially Expressed Genes
The number of differentially expressed genes (DEGs) varied significantly for each

comparison group (Table 3.2) at each timepoint. Only five genes (all at 1 hr) were significantly
different between normal vs. lamellar groups, whereas many genes were different between
woven vs. normal and woven vs. lamellar. We chose to focus on woven vs. lamellar comparisons
(Figure 3.1) because of the apparent similarity between expression levels in lamellar and normal
groups and because our main objective was to determine the differences between woven and
lamellar bone formation. As illustrated (Figure 3.1), some genes were differentially regulated
across multiple timepoints, while other genes were differentially regulated at a single timepoint.

Table 3.2. Comparison of the number of DEGs between groups at 1 hr, day 1 and day 3. The
woven vs. lamellar DEGs were further analyzed using GeneGo software.
Woven vs.
Lamellar
Woven vs.
Normal
Lamellar vs.
Normal

1 hr

Day 1

Day 3

395

5883

5974

749

5869

4916

5

0

0
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Figure 3.1. A number of genes were differentially regulated at 1 hr, 1 and 3 days post-loading for
damaging (woven) vs. non-damaging (lamellar) loading from microarray analysis. Some of the
genes were differentially regulated across several timepoints and others were unique to a single
timepoint.

3.5.2

Top 10 Canonical Pathways
Analysis of the top ten canonical pathways (GeneGo) activated by woven vs. lamellar

loading was completed at each timepoint. At 1 hr after loading the majority of the pathways were
related to an inflammatory response (7/10 pathways) with the addition of two pathways related to
development. The inflammatory response persisted at day 1 (5/10 pathways) with the addition of
cytoskeletal remodeling activation (2/10 pathways). By day 3, the inflammatory response had
subsided (0/10 pathways), but cytoskeletal remodeling still played a major role (3/10 pathways)
and a development pathway was evident again (1/10 pathways) (Figure 3.2).
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Figure 3.2. The total number of differentially regulated genes shown here is based on overlaying
of our data onto predefined canonical pathway maps provided by GeneGo. On each pathway,
genes were counted if their expression was significantly different between woven and lamellar
bone.

3.5.3

Inflammatory Response
Analysis of microarray data revealed that several components of various innate

inflammatory response pathways were upregulated after damaging loading (Table 3.3). As early
as one hour after loading there was upregulation of several cell surface proteins/receptors know
to function in mechanotransduction (Dinarello 2009), such as integrins, toll-like receptors (TLRs)
and interleukin receptors (specifically Il1r1). Toll-like receptor 2 (Tlr2) was selected as one
indicator of this level of inflammation, and its expression was confirmed by qRT-PCR (Figure 3.3;
Table 3.4). Both microarray and qRT-PCR data showed Tlr2 to be upregulated at all timepoints,
peaking on day 1. Select intermediate proteins in inflammatory response pathways (such as
Myd88 of TLR pathways) were also upregulated, as were some terminal transcription factors
which are responsible for regulating various pro-inflammatory responses, such as NF-kB, AP-1
and NF-AT family members (Ono 2008) (Table 3.3).
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NF-κB was of interest as it appeared in a large number of the significant maps produced
by GeneGo, and an inhibitor of NF-κB (Nfkbia) was one of the five genes to be upregulated in the
lamellar to normal comparison. Different combinations of NF-κB subunits form active dimers and
several of these subunits (Nfkb1, Nfkb2 and Rel) were upregulated in woven as compared to
lamellar. Nfkb1 was chosen for confirmation by qRT-PCR, as it was slightly upregulated at 1 hr,
before declining towards normal levels on days 1 and 3 in the microarray. qRT-PCR also showed
Nfkb1 to be upregulated but expression increased on days 1 and 3 (Figure 3.3, Table 3.4).
Lamellar expression did not differ from control at any timepoint for Nfkb1.
Other components of the NF-κB signaling pathway were also differentially regulated,
including members of the I-κB family such as Bcl3, Nkbiz and Nkbie (Renner 2009). Nfkbia, which
is both an inhibitor and a transcriptional target of NF-κB (Renner 2009), was also upregulated. In
the microarray, Nfkbia was up at 1 hr in lamellar as compared to normal (fold change 2.0). qRTPCR did show Nfkbia was also upregulated at 1 hr in the lamellar group. However, unlike in the
microarray, Nfkbia was upregulated in the woven group at all timepoints, most significantly at 1 hr
by qRT-PCR.
The microarray also showed the upregulation of transcription factors, as well as several
targets of NF- κB including pro-inflammatory cytokines (Il1a Il1b, Il6) (Dimitriou 2005),
chemokines (Cxcl1, 2 and 10) and cell adhesion molecules (Icam1, Sele). Interleukin 6 and both
the alpha and beta subunits of Il1 were greatly upregulated. Several receptors (Il1r1 and Il8rb for
example) were also up. Socs1, which takes part in the negative feedback of cytokines (Dimitriou
2008), was also greatly upregulated across all three days suggesting that mechanisms for the
attenuation of the inflammatory response were also active in this time range.
Interleukin-6 was chosen as an indicator of pro-inflammatory cytokines. In our study,
qRT-PCR confirmed the dramatic upregulation of Il6 seen in the microarray. Like in the
microarray, expression peaked at 1 hr and declined thereafter with levels still well above normal.
Expression of Il6 was upregulated at 1 hr by over 500 fold on qRT-PCR, and near 50 fold on the
microarray (Tables 3.3 and 3.4). Expression was not significant for lamellar compared to normal
by either method.
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Figure 3.3. qRT-PCR relative expression (delta CT) of genes related to inflammation. Genes
were upregulated at all timepoints for woven bone with the exception of Nfkbia on day 1. In
contrast, only Nfkbia at 1 hr was upregulated for lamellar bone. The inflammation marker Il6 is
increased over 500 fold 1 hr after damaging loading. *p<0.05 vs. normal

3.5.4

Angiogenic Response
Angiogenesis is known to respond early to mechanical loading (Matsuzaki 2007,

McKenzie 2009, Wohl 2009), and the differential regulation of a variety of angiogenic genes in the
microarray supports this. The constitutive beta subunit (Arnt) of hypoxia-inducible factor (Hif1a, a
central component of angiogenesis-osteogenesis coupling) was upregulated, as were the
inducible alpha subunit and coactivators found in the nucleus such as Creb1. A HIF-1a inhibitor
(Egln1) was downregulated.
Chemokines also promote angiogenesis (Rosenkilde 2004, Salcedo 2003). In our study,
Cxcl1, -2, -6 and the receptor Il8rb were upregulated while Ppbp was downregulated. However,
angiostatic chemokines (Rosenkilde 2004, Salcedo 2003) were also differentially regulated, as
Cxcl10 (formerly known as IP-10), -13 and the receptor Cxcr3 (of Cxcl10) were upregulated to
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some extent. Cxcl10 was selected for further confirmation by qRT-PCR (Figure 3.4). Upregulation
of Cxcl10 was significant 1 hr after damaging loading and continued to increase through day 3.
Another chemokine and its receptor, Ccl20 and Ccr2 respectively, were upregulated, as
were other genes influencing chemotaxis such as Ccl7 (Ghadjar 2009). Sele was chosen to
represent chemotaxis in the endothelia (Krishnan 2001) and for further confirmation by qRT-PCR.
The microarray showed Sele to be upregulated at all three timepoints for woven bone, peaking at
1 hr. The qRT-PCR showed Sele to be upregulated significantly in the woven group, but in
contrast to the microarray expression peaked on day 1 (Figure 3.4). Expression of Sele stayed
near control levels in the lamellar group.
Genes associated with blood flow regulation and vasodilation were also differentially
expressed. Ptgs2/Cox2 was upregulated in the microarray data, as was Nos3 (a constitutive form
of NOS), and Ap1 and Creb1 (two transcription factors for Ptgs2/Cox2). Cebpb, a regulator of
COX-2, was upregulated at 1 hr and day 1 but downregulated on day 3. Ptgs2/Cox2 was selected
for further verification by qRT-PCR and was upregulated at all timepoints in the woven group, but
declined towards normal by day 3 (Figure 3.4, Table 3.4).

Figure 3.4. Relative expression changes for angiogenic markers. All genes were upregulated at
all timepoints for woven bone, but never for lamellar bone. Both Sele and Ptgs2/Cox2 are
positively related to increased vasculature with expression peaking on day 1. In contrast, Cxcl10
is angiostatic and peaks on day 3. *p<0.05 vs. normal; legend in Figure 3.3.
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3.5.5

Osteogenic Response
Mechanical loading is known to greatly influence bone modeling (Iqbal 2005, Robling

2006b), and various aspects of this process were differentially regulated in our microarray,
starting with mechanoreceptors such as cadherins (for example Cdh16, Fat3 and Cdh19) and
integrins (Itgax, Itgal, Itgam and Itgb2) (Table 3.3). Though several DEGs were part of the
canonical Wnt-pathway, the pathway as a whole was not clearly or dramatically regulated in one
specific direction. Wnts were not differentially regulated though their receptors were. Lrp5 was
suppressed as was Fzd8 (slightly), while Fzd1 was slightly upregulated. Dkk1 and Sfrp4
(inhibitors) were downregulated. Both Dishevelled (Dvl1) and casein kinase I (Csnk1a1) form a
complex with beta-catenin, targeting it for ubiquination (i.e. suppressing the pathway). Though
Dvl1 was slightly down, an isoform of Csnk1a1 was slightly up as was one of its nuclear partners,
Tcf7. While the direction of regulation of the pathway in general was rather questionable,
sclerostin (Sost) seemed to be a clear point of Wnt-pathway regulation. Like seen in previous
studies (Bonewald 2008, Kubota 2009), Sost was greatly suppressed in the microarray after
damaging loading. qRT-PCR of Sost confirmed this pattern, but with much greater fold changes
(down 20-fold on day 1) (Figure 3.5). Sost expression was inhibited in the lamellar group on day 1
(P=0.055), but was not different from normal at 1 hr or day 3.
BMP pathways were also differentially regulated in woven as compared to lamellar bone
formation. TGF-β may initiate BMP synthesis, as well as having chemotactic, proliferative and
matrix remodeling effects of its own (Dimitriou 2005). Our data show mixed regulation of three
types of TGF-β: Tgfb1 up, Tgfb2 down and Tgfb3 down on day 1 and up on day 3. Bmp2 itself is
upregulated, though only slightly, while Bmp3, -3b (Gdf10), - 4, -6 and -7 were downregulated.
The receptors for BMP-5, 6, 7, and 8, Acvr2b and Acvr1 were also downregulated, though just
slightly for the latter. The downstream transcription factors Smad1 and Smad5 were upregulated,
though again only slightly. The pathways were most clearly modulated by the downregulation of
antagonists (Dean 2009) such as the previously mentioned Sost, as well as Nbl1, Bambi, Fst,
Grem1, Chrd and inhibitory SMADs (Smad6 and Smad7) (Table 3.3).
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Many genes related to cell proliferation and differentiation were differentially regulated in
the microarray. Osteoprotegerin (Tnfrsf11b) is an inhibitor of osteoclast differentiation and
activation, as is the upregulated Il6. Tnfrs11b was upregulated on day 1, though neither RANK
nor its receptor was differentially regulated. Cell cycle regulation genes such as Ccnd1, Cdk4,
Cdc2, and E2f1 were up, while E2f6 and members of the Rb family (Rbl2, Rbl1) were down.

3.5.6

Bone Remodeling Response
Genes associated with matrix remodeling were also differentially regulated, specifically

those expressed by osteoclasts. Members of the cathepsin family (Ctsd, Ctsb, Ctss and Ctsv)
(Lecaille 2008) along with Csf1 and Myc were upregulated to some extent. Ctsc and Ctsk both
localize predominately in osteoclasts (Georges 2009, Zhao 2009), though the first was
upregulated and the second downregulated. Cathepsin K was chosen as an osteoclast activity
indicator for confirmation with qRT-PCR (Figure 3.5; Table 3.4). Ctsk was slightly downregulated
on day 1 in the microarray, whereas qRT-PCR showed it to be around normal levels at 1 hr and
day 1 but upregulated on day 3. Some inhibitors of Ctsk such as Il6 and Tnfrsf11b were
upregulated in the microarray, while others such as Ctsc were just slightly down.
Matrix degradation is key for remodeling, as well as for increased cell mobility. MMPs in
general function in this capacity (Georges 2009, van Hinsbergh 2008) and Mmp13 was chosen as
an indicator of these processes. In the microarray, Mmp13 was upregulated greatly on day 1, and
less so on day 3, a pattern seen again in qRT-PCR (Figure 3.5). Important transcriptional
regulators of MMP-13, were also differentially regulated: some subunits of AP-1 were slightly up
and others slightly down, while Etv4 was much more strongly downregulated.
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Figure 3.5. Relative expression changes of osteogenic genes associated with matrix modeling
and remodeling. Sost, a bone formation inhibitor is downregulated at all timepoints for woven
bone and neared significance for lamellar bone at day 1 (p=0.055). Mmp13 and Ctsk are
markers of bone remodeling and both are upregulated at later timepoints. *p<0.05 vs. normal;
legend in Figure 3.3.

Table 3.3.

Differential expression of genes from the microarray.

Values are fold change

difference between woven and lamellar bone formation. An x indicates the fold change between
loading conditions was not significant at that timepoint.
Woven Over Lamellar
Category
Inflammation

Gene Name
Adaptor-related protein complex 1, beta
1 subunit
Adaptor-related protein complex 1,
sigma 2 subunit
Activating transcription factor 1
Activating transcription factor 4 (taxresponsive enhancer element B67)
Activating transcription factor 5
Activating transcription factor 6 beta
Activating transcription factor 7
B-cell CLL/lymphoma 3
FBJ osteosarcoma oncogene
Intercellular adhesion molecule 1
Interleukin 1 alpha
Interleukin 1 beta
Interleukin 1 receptor, type I
Interleukin 6
Interleukin 8 receptor, beta
Integrin alpha L
Integrin alpha M
Integrin alpha X
Integrin beta 2
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Gene
Symbol

1 hr

Day 1

Day 3

Ap1b1

x

1.73

1.69

Ap1s2

x

-1.36

Atf1

x

1.65

1.27

Atf4

x

x

-1.26

Atf5
Atf6b
Atf7
Bcl3
Fos
Icam1
Il1a
Il1b
Il1r1
Il6
Il8rb
Itgal
Itgam
Itgax
Itgb2

x
x
x
15.96
x
3.47
18.14
20.88
3.91
53.62
x
x
x
x
x

-2.03
1.54
x
17.57
3.29
2.57
x
7.06
7.15
45.97
29.01
79.37
7.69
7.35
6.66

-2.69
1.56
-1.42
5.37
x
x
x
2.45
x
4.85
x
x
x
x
x

Jun dimerization protein 2
Jun oncogene
Jun B proto-oncogene
Myeloid differentiation primary response
gene 88
Nitric oxide synthase 2, inducible
Nuclear factor of activated T-cells,
cytoplasmic, calcineurin-dependent 4
Nuclear factor of kappa light polypeptide
gene enhancer in B-cells 1
Nuclear factor of kappa light polypeptide
gene enhancer in B-cells 2, p49/p100
Nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor, alpha
Nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor,
epsilon
Nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor, zeta
Prostaglandin E receptor 2, subtype
EP2
Prostaglandin E receptor 4 (subtype
EP4)
V-rel reticuloendotheliosis viral
oncogene homolog (avian)
Suppressor of cytokine signaling 1
Toll-like receptor 2
Toll-like receptor 4
Angiogenesis

Aryl hydrocarbon receptor nuclear
translocator
Chemokine (C-C motif) ligand 12
Chemokine (C-C motif) ligand 20
Chemokine (C-C motif) ligand 7
Chemokine (C-C motif) receptor 2
Chemokine (C-C motif) receptor 6
CCAAT/enhancer binding protein
(C/EBP), alpha
CCAAT/enhancer binding protein
(C/EBP), beta
cAMP responsive element binding
protein 1
Chemokine (C-X-C motif) ligand 1
(melanoma growth stimulating activity,
alpha)
Chemokine (C-X-C motif) ligand 10
Chemokine (C-X-C motif) ligand 13
Chemokine (C-X-C motif) ligand 2
Chemokine (C-X-C motif) ligand 6
(granulocyte chemotactic protein 2)
Chemokine (C-X-C motif) receptor 3
EGL nine homolog 1 (C. elegans) [Hifprolyl hydroxylase]
Hypoxia-inducible factor 1, alpha
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Jdp2
Jun
Junb

x
x
5.98

1.64
-1.57
3.93

-1.74
1.96

Myd88

2.54

3.87

2.2

Nos2

50.17

7.49

x

Nfatc4

x

x

1.33

Nfkb1

x

2.06

x

Nfkb2

1.76

1.408

1.33

Nfkbia

x

x

-1.41

Nfkbie

x

4.8

6.25

Nfkbiz

25.78

6.82

2.81

Ptger2

x

89.6

6.38

Ptger4

x

4.39

1.95

Rel

x

2.48

x

Socs1
Tlr2
Tlr4

13.29
3.19
x

9.52
9.82
3.79

6.54
2.83
x

Arnt

x

x

1.74

Ccl12
Ccl20
Ccl7
Ccr2
Ccr6

x
85.74
24.49
x
x

26.49
3574
55.06
3.43
6.84

7.78
150.3
6.43
x
2.45

Cebpa

x

2.63

x

Cebpb

1.64

1.69

-1.5

Creb1

x

1.94

1.71

Cxcl1

61.94

5.7

x

Cxcl10
Cxcl13
Cxcl2

11.67
x
66.16

7.98
5.22
16.25

9.99
2.84
x

Cxcl6

x

37.59

8.36

Cxcr3

x

1.8

x

Egln1

x

-2.33

-2.32

Hif1a

x

x

1.94

subunit (basic helix-loop-helix
transcription factor)
Interferon gamma receptor 1
Interferon gamma receptor 2
v-Ki-ras2 Kirsten rat sarcoma viral
oncogene homolog
Nitric oxide synthase 3, endothelial cell
Peroxisome proliferator-activated
receptor gamma, coactivator 1 alpha
Pro-platelet basic protein (chemokine
(C-X-C motif) ligand 7)
Prostaglandin-endoperoxide synthase 2
Selectin, endothelial cell
Osteogenesis

Activin A receptor, type I
Activin A receptor, type IIB
BMP and activin membrane-bound
inhibitor, homolog (Xenopus laevis)
Bone morphogenetic protein 2
Bone morphogenetic protein 3
Bone morphogenetic protein 4
Bone morphogenetic protein 6
Bone morphogenetic protein 7
Cyclin D1
Cell division cycle 2, G1 to S and G2 to
M
Cadherin 16
Cadherin 19, type 2
Cyclin-dependent kinase 4
Chordin
Catenin (cadherin associated protein),
beta 1
Dickkopf homolog 1 (Xenopus laevis)
Dishevelled, dsh homolog 1
(Drosophila)
E2F transcription factor 1
E2F transcription factor 6
FAT tumor suppressor homolog 3
(Drosophila)
Follistatin
Frizzled homolog 1 (Drosophila)
Frizzled homolog 8 (Drosophila)
Growth differentiation factor 10
Gremlin 1, cysteine knot superfamily,
homolog (Xenopus laevis)
Low density lipoprotein receptor-related
protein 5
Neuroblastoma, suppression of
tumorigenicity 1
Retinoblastoma 1
Retinoblastoma-like 2
Secreted frizzled-related protein 4
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Ifngr1
Ifngr2

x
x

1.87
1.59

1.21
x

Kras

x

x

1.48

Nos3

1.95

2.26

1.48

Ppargc1a

x

-14.41

-4.02

Ppbp

x

-7.15

-7.91

Ptgs2/Cox2
Sele

9.06
6.79

4.78
3.36

1.81
2.06

Acvr1
Acvr2b

x
x

-1.31
-2.02

x
-2.29

Bambi

x

-1.72

x

Bmp2
Bmp3
Bmp4
Bmp6
Bmp7
Ccnd1

x
x
x
x
x
x

1.82
-1.68
-2.31
-3.68
x
1.46

x
x
x
-2.61
-2.64
1.89

Cdc2

x

x

4.54

Cdh16
Cdh19
Cdk4
Chrd

x
x
x
x

51.56
-1.56
1.9
-2.31

x
x
1.83
x

Ctnnb1

x

x

1.72

Dkk1

-5.74

-2.75

x

Dvl1

x

-1.94

x

E2f1
E2f6

x
x

3.86
-2.22

6.18
-3.04

Fat3

x

x

2.25

Fst
Fzd1
Fzd8
Gdf10

x
x
-1.56
x

x
1.71
-1.7
-1.64

-2.18
1.61
x
-1.54

Grem1

x

-11.51

-8.98

Lrp5

x

-1.85

-1.41

Nbl1

x

-3.62

-2.68

Rb1
Rbl2
Sfrp4

x
x
x

x
-1.48
x

-1.41
-1.29
-1.476

SMAD family member 1
SMAD family member 5
SMAD family member 6
SMAD family member 7
Sclerosteosis
Transcription factor 3
Transcription factor 7, T-cell specific
Transforming growth factor, beta 1
Transforming growth factor, beta
Transforming growth factor, beta 3
Tumor necrosis factor receptor
superfamily, member 11b
Bone
Remodeling

Other

Colony stimulating factor 1
(macrophage)
Cathepsin B
Cathepsin C
Cathepsin D
Cathepsin K
Cathepsin L1
Cathepsin S
Cystatin C
Ets variant 4
Matrix metallopeptidase 13
Myelocytomatosis oncogene
Nerve growth factor (beta polypeptide)
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Smad1
Smad5
Smad6
Smad7
Sost
Tcf3
Tcf7
Tgfb1
Tgfb2
Tgfb3

1.32
x
x
x
x
x
x
x
x
x

x
1.56
-1.67
-1.89
-18.12
-1.92
2.35
x
x
-1.72

x
1.72
x
-1.73
-16.24
x
3.99
2.04
-1.95
1.46

Tnfrsf11b

x

2.54

x

Csf1

1.9

1.57

x

Ctsb
Ctsc
Ctsd
Ctsk
Ctsl1
Ctss
Cst3
Etv4
Mmp13
Myc

x
x
x
x
x
x
x
x
x
4.46

2.68
2.43
2.16
-1.51
1.94
2.98
-1.24
-12.75
21.04
2.45

1.7
1.82
x
x
x
x
x
-4.08
3.58
1.74

Ngf

7.58

12.19

3.77

Table 3.4. Relative fold changes (loaded over normal) for gene expression analysis done using
qRT-PCR. *p<0.05 vs normal; #p<0.05 vs lamellar.
Gene Name
interleukin 6
toll-like receptor 2

Lamellar
Woven
Gene Qiagen primer
Symbol
num.
1 hr Day 1 Day 3
1 hr
Day 1 Day 3
#
#
#
Il6
QT00182896 1.21 1.12 -1.23 504.17* 212.34* 38.59*
Tlr2

nuclear factor of kappa light
polypeptide gene enhancer in B- Nfkb1
cells 1
nuclear factor of kappa light
polypeptide gene enhancer in B- Nfkbia
cells inhibitor, alpha
selectin, endothelial cell

Sele

prostaglandin-endoperoxide
Ptgs2
synthase 2
(Cox2)
chemokine (C-X-C motif) ligand
Cxcl10
10
sclerosteosis
Sost
matrix metallopeptidase 13
Mmp13
cathepsin K
nerve growth factor

Ctsk
Ngf

1.54

1.46

3.87*#

24.21*# 17.76*#

QT01577975 -1.03 1.24

1.16

1.58*#

3.31*#

4.64*#

QT01600956 2.18* 1.09 -1.09

2.90*#

1.31

1.83*#

QT00179018 -1.08 1.96

1.36

10.37*# 18.52*# 9.63*#

QT00417438

1.06

QT00192934

1.13

1.89

1.43

16.39*# 16.85*# 8.58*#

QT01082354

1.01

2.31

1.47

10.41*# 12.28*# 45.71*#

QT00418558 -1.30 -1.57 1.37
QT00385686 -1.40 -2.66 -2.57

-3.44*# -19.77*# -8.07*#
1.08
9.23*# 4.28*#

QT00375599 -1.09 -1.09 -1.44
QT01800344 0.85 1.33 1.24

-1.13
3.24*#

-1.11 2.85*#
22.63*# 14.07*#

3.6 Discussion
The objective of our study was to identify gene expression differences between woven
bone (induced using a damaging fatigue loading protocol) and lamellar bone (induced using a
non-damaging loading protocol). Using a microarray we saw a higher number of DEGs for woven
compared to lamellar bone formation. A total of 395 genes were differentially expressed between
woven and lamellar bone formation 1 hr after loading, while 5883 and 5974 genes were
differentially expressed on days 1 and 3, respectively. There were many inflammatory factors
upregulated as early as 1 hr after damaging loading, such as toll-like receptors and proinflammatory cytokines. We expanded our previous results related to angiogenesis (McKenzie
2009), finding many differentially regulated genes associated with hypoxia and vasodilation. We
examined bone-related genes, including Wnt and BMP pathways, to find that stimulation of
woven bone formation both activates and attenuates various genes along these pathways.
Finally, results demonstrated activation of bone remodeling pathways at later timepoints following
damaging loading.
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Woven bone formation is an important aspect of fracture repair. In fracture healing,
woven bone forms as part of a multi-step process of both intramembranous and endochondral
bone formation (Einhorn 1998, Gerstenfeld 2003a). Induction of a stress fracture leads to a more
conservative healing response than for fracture repair, where the cartilaginous phase is omitted
(Tami 2003, Uthgenannt 2007a). Thus, the stress fracture healing model can be used to study
woven bone formation without the complexities involved in fracture healing, and with a reduction
in the timeline between injury and repair.
The significance of the inflammatory response during the early stages of woven bone
formation (indicated by a number of GeneGo pathway maps) requires further investigation. An
inflammatory response is seen as the primary event after fracture healing (Heiner 2006, Khan
2008, Rundle 2006), and our data indicate a similar event for stress fracture healing. Most of the
canonical pathways represented by the GeneGo maps focused on innate inflammatory responses
and were in general upregulated. This upregulation began with several cell surface
proteins/receptors know to function in mechanotransduction such as integrins, toll-like receptors
(TLRs) and interleukin receptors (specifically Il1r1). In general, TLRs can be activated by PAMPS
(pathogen associated molecular patterns found on microbial molecules) but also by mechanical
strain and general cellular stress (Dinarello 2009). In woven bone formation Tlr2 is upregulated at
all timepoints but was absent for lamellar bone formation, confirming an inflammatory response
for woven but not lamellar bone. These pathways in general lead to transcription factors such as
NFκB, which regulates numerous pro-inflammatory responses including cytokines (Il1, Il6, TNFalpha), chemokines (IL-8) and cell adhesion molecules (ICAM1, E-selectin). The overall
regulation of NF-κB signaling during woven bone formation is complicated by the numerous
autoreguatory feedback loops that attenuate the NF-κB response. For example, I-κBα is both an
inhibitor and a transcriptional target of NF-κB. In general, a wide range of pro-inflammatory genes
known to be targets of these pathways were activated, specifically cytokines. Proinflammatory
cytokines such as IL-1, IL-6 and TNF-alpha have been shown to be secreted by macrophages as
well as by cells originating from mesenchymal cells located in the periosteum. In previous studies,
they peak in expression one day after fracture and decline rapidly to low levels by day three
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(Dimitriou 2005). While TNF-alpha was not differentially regulated in the microarray, Il6 and both
Il1a and Il1b were greatly upregulated. Socs1, which takes part in the negative feedback of
cytokines, was also upregulated across all three days suggesting that mechanisms for the
attenuation of the immune response were also active in this time range. IL-6 and other proinflammatory cytokines serve as a central hub for other down-stream responses to tissue
damaging, including angiogenesis, ECM synthesis and chemotactic effects on other inflammatory
cells (Robling 2006b).
VEGF-A is considered crucial for angiogenesis and our previous qRT-PCR studies have
shown its upregulation at all three timepoints (McKenzie 2009, Wohl 2009), although the
microarray showed no significant differential regulation of it, nor of its receptors. HIF signaling is
central to angiogenesis-osteogenesis coupling in osteoblasts, particularly because of its
regulation of VEGF (Berchner-Pfannschmidt 2008, Lohela 2009). Interestingly, recent studies
have shown that Vegf can be induced independently of Hif1a, by Ppargc1a (Arany 2008), which
was greatly downregulated in this study. VEGF transcription is also promoted under hypoxia
conditions by K-ras, as well as JunB and NF-kB. All three were upregulated to some extent.
These findings suggest a more complex network of VEGF-A regulation that could be further
investigated.
In prior studies we have seen an increase in vasculature on histology (Matsuzaki 2007)
and in genes associated with angiogenesis (McKenzie 2009, Wohl 2009) following woven bone
formation, but not lamellar bone formation. Microarray results expanded our previous knowledge
by reporting prostaglandin signaling and vasodilation factors, such as Ptgs2/Cox2. Expression of
Cox2 has also been reported to be required for fracture healing (Simon 2002). However,
consistent with our reports, Cox2 expression is not required for lamellar bone formation in the
ulna (Alam 2005, Li 2002). Vasodilation is controlled to some extend by the biosynthesis and
release of nitric oxide and prostaglandins, controlled by constitutive and inducible forms of nitric
oxide synthase (NOS) and cyclooxygenase, respectively (Mollace 2005, Tsuji 2006). The
inducible isoforms are sensitive to inflammation, and osteocytes activated by fluid shear stress
have been also shown to produce both prostaglandins and nitric oxide (NO) (Robling 2006b),
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both of which were highly upregulated in our study. In contrast to our microarray results, which
did not suggest a relationship between NO and lamellar bone formation, inhibition of NO was
shown to decrease endocortical lamellar bone formation in the rat tibia (Turner 1996). However,
the difference may be due to the skeletal site studied, as Cox2 inhibition experiments in the rat
have shown differences in lamellar bone formation between the tibia and ulna (Li 2002).
Microarray findings also pointed to a number of anti-angiogenic genes that were
activated. CXCL-10 in particular, it is thought to be involved in (or perhaps triggers) the involution
of microvasculature, when angiogenesis stops or even regresses as the nutrient demand of the
tissue decreases. Our results demonstrate a significant upregulation of Cxcl10, with expression
peaking on day 3. Overall, Cxcl10 may be central to attenuation of the angiogenic response and
other anti-angiogenic factors brought to light by the microarray could be further examined to
expand our understanding of this part of the response to mechanical loading during woven bone
formation.
Prior studies have shown mechanical stimulation, such as the loading done in this
experiment, to greatly influence bone formation (Bentolila 1998, Uthgenannt 2007a). Osteocytes
are thought to be particularly responsive to mechanical forces, as are osteoblasts, while
osteoclasts are affected less directly (Iqbal 2005, Robling 2006b). The canonical Wnt signaling
pathway is central to bone remodeling and has been shown to be directly affected by mechanical
loading through the suppression of sclerostin (Sost) in osteocytes (Robling 2006b). Sost normally
inhibits the Wnt-pathway, in particular through its interactions with LRP5 (Dinarello 2009). A
suppression of Sost would therefore lead to an increase in osteogenesis, which was present in
our study.
Pathways involving BMPs, specifically that of BMP-2 are critical for osteogenesis,
particularly because of their interaction with angiogenic factors such as VEGF. TGF-β may initiate
BMP synthesis, as well as having chemotactic, proliferative and matrix remodeling effects of its
own (Dimitriou 2005). Although we have seen increased expression in Bmp2 for both woven and
lamellar bone in past experiments (McKenzie 2009), expression of BMP’s in the microarray was
not dramatic. In agreement with our findings on BMPs, another microarray fracture study also
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found weak or no expression of common bone cytokines including BMP2, 4, 6 and 7 (Heiner
2006).
Bone remodeling is an important part of the damage-repair process. The tissue sample
used for microarray analysis consisted of both new periosteal bone and original cortical bone.
The upregulation of matrix remodeling genes may be due to remodeling at sites of damaged
matrix in the cortical bone that are occurring simultaneously with new bone modeling on the
periosteal surface. There was evidence of bone remodeling following damaging, but not nondamaging loading. Examining osteoclast function using Ctsk (primarily expressed in osteoclasts),
demonstrated an overexpression in woven bone at day 3. This likely indicates the activation of
osteoclasts to repair cracks in the cortex of the ulna (Hsieh 2002). It is clear from the differential
regulation of these genes that osteoclasts play an active role after damaging fatigue loading, but
not with non-damaging lamellar loading. MMPs can activate certain cell adhesion molecules,
matrix components and cytokines by enzymatic cleavage (Kawamoto 2004). Upregulation of
Mmp13 in our study confirms that the breakdown of matrix components is occurring in woven but
not lamellar bone. Promoters of MMP-13 are also known to be upregulated by RUNX2 during
osteoblast differentiation, and we’ve previously shown Runx2 to be upregulated during woven
bone, but not lamellar bone formation (McKenzie 2009).
One additional area of interest is the nervous system response to loading. Our microarray
data saw a significant increase in nerve growth factor in response to damaging loading, which
was confirmed using qRT-PCR (Tables 3.3 and 3.4). The response was upregulated as early as
one hour after loading, but only for woven bone formation. Lamellar bone did not show any
increase in nerve growth factor expression. Nerve-related genes have also been seen in fracture
healing (Meyer 2004). As opposed to a response localized at the site of damage, an additional
aspect of animal loading is the possibility of a whole body nervous system response (Wu 2009).
Our loading model demonstrates a significant increase in gene expression at the loading site
compared to the contralateral ulna, but additional skeletal sites were not examined for changes in
gene expression.
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The study was not without limitations. The selected timepoints for expression analysis
were based on prior studies and we thought they would give us a good indication of the early
molecular events that differentiate woven from lamellar bone formation. Also, our microarray
analysis was limited to the canonical pathways available in the GeneGo software. However, this
bias was only incorporated into our top ten canonical pathway analysis, as GeneGo has the
option to create and study networks generated from user input. Finally, differences in sensitivity
between microarray and qRT-PCR were clearly demonstrated in our data. While the fold change
differences in expression were not identical, we saw the same general patterns of increasing or
decreasing expression using the two methods.
A microarray is an extremely powerful tool that can be used to assess the expression of
thousands of genes simultaneously. Using this assay, we were able to distinguish the molecular
response between woven and lamellar bone formation. A complete understanding of the
molecular mechanisms that regulate bone formation in the adult skeleton will be informative to
allow development of drugs or therapies to help promote rapid bone formation in a clinical setting.

3.7 Conclusions
Use of a whole genome microarray has allowed us to confirm the gene expression
responses from our prior study (McKenzie 2009) and has identified other genes and pathways
that differ between woven and lamellar bone formation. An overview of the major responses
associated with woven bone formation depict a strong early inflammatory response, followed by
an increase in angiogenesis and finally upregulation of osteogenic genes (Figure 3.6). Validation
of these pathways using select target genes (qRT-PCR) confirmed their differential expression in
our study.

The vast amount of data present in the microarray can be used to show how

expression of genes is choreographed to promote the sequential steps in bone formation.
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Figure 3.6. In combination with our previous report (McKenzie 2009), we have created an
overview of the molecular response comparing woven to lamellar bone formation. There is an
early immune response that persists through time but tends to decrease in expression. The
vascular response is also a major component of woven bone formation and it precedes
osteogenesis. Osteogenic indicators are differentially regulated shortly after loading, but seem to
increase over time. Finally, bone remodeling markers are activated later to repair bone damage.
Most of these changes likely occur within the first week or two following loading, although our
data only goes through day 3.
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4

Explorations Into the Use of Angiogenic Inhibitors TNP-470, SU5416 and YC-1

Following Fatigue Loading of the Rat Ulna

4.1

Abstract
In the rat ulna fatigue model, angiogenic gene expression and vascular changes precede

osteogenic changes during woven bone repair. Our objective was to determine the effects of
angiogenesis on woven bone formation in the rat ulna following fatigue injury using three
angiogenic inhibitors. The first inhibitor, TNP-470, acts on methionine aminoptidase-2, and is
reported to limit endothelial cell proliferation and vessel formation. The second inhibitor, SU5416,
targets VEGF receptor 2. And the third inhibitor, YC-1, acts upstream of VEGF, affecting HIF1a
at a transcriptional level. We hypothesized that administration of TNP-470 1) restricts
upregulation of angiogenic and osteogenic genes associated with woven bone formation and 2)
impairs vessel formation and blood flow. Furthermore, we hypothesized that administration of
TNP-470, SU5416 or YC-1 reduces woven bone area following fatigue loading in the rat ulna.
Forelimbs of male rats were loaded in a single bout of cyclic (2 Hz) axial compression at a
constant peak force. Half of the rats received daily injections of an angiogenic inhibitor (either as
a systemic injection or a local injection in the forelimb), while the other half received only the
vehicle. TNP-470 administration significantly diminished gene expression of platelet endothelial
cell adhesion marker (Pecam), and osteogenic markers (bone sialoprotein and osterix) measured
three days after loading. Vascular perfusion and [15O] water PET demonstrated increased
vascularity and blood flow in loaded forelimbs vs. controls, but TNP-470 did not diminish these
loading-induced changes. Nevertheless, there was a 60% reduction in woven bone area seven
days after loading (p<0.001) in TNP-470 treated ulnae (0.45 mm2) compared to vehicle alone
(1.15 mm2). Unexpectedly, neither SU5416 nor YC-1 reduced woven bone area. In conclusion,
the angiogenic inhibitor TNP-470 impairs osteogenic gene expression and dramatically reduces
woven bone formation following fatigue loading, but, surprisingly, did not affect angiogenic
outcomes.
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4.2

Key Terms
Angiogenesis, rat, woven bone, loading, inhibition, stress fracture

4.3

Introduction
There is an increasing amount of evidence indicating a crucial role for angiogenesis in

skeletal development and repair. The role of angiogenesis has been documented in distraction
osteogenesis (Fang 2005, Jazrawi 1998), fracture repair (Glowacki 1998, Hausman 2001, Street
2002) and skeletal development (Colnot 2001, Ferrara 2001, Pechak 1986). The increase in
angiogenesis at the site of damage has been postulated to introduce additional osteoblast
progenitors into the area. These progenitors eventually mature to increase bone formation.
Many different drugs have been taken from the cancer research field and applied to
angiogenic inhibition in bone. Fracture studies have shown the importance of angiogenesis on
healing in bone formation (Pacicca 2003), by inhibiting vessels using small molecules or a drug.
TNP-470, an angiogenic inhibitor, acts by inhibition of methionine aminoptidase-2 (Sin 1997) and
has been reported to limit endothelial, but not osteoblast, cell proliferation and vessel formation
(Friis 2006, Street 2002, van der Schaft 2004, Wang 2000). Angiogenic inhibition by TNP-470
impairs osteogenesis in fracture repair (Hausman 2001) and distraction osteogenesis (Fang
2005). These studies highlight the importance of angiogenesis in a healing setting where large
amounts of bone formation are required to help stabilize the injury.
SU5416 and YC-1 have also been shown to reduce vessel formation. The first inhibitor,
SU5416, targets VEGF receptor 2 (Fong 1999, Zhong 2004) and was shown to dramatically
reduce vessel formation in vivo in wound healing (Haroon 2002) and tumor models (Huss 2003,
Katanasaka 2008). The second inhibitor, YC-1, acts upstream of VEGF affecting HIF-1a
expression at a transcriptional level (Ko 1994). Similar to SU5416, this drug was shown to
reduce vessel formation in several tumor models (Shin 2007, Yeo 2003).
In fracture healing bone forms as part of a multi-step process of both intramembranous
and endochondral bone formation (Einhorn 1998, Gerstenfeld 2003a), which makes it difficult to
isolate woven bone formation from the cartilaginous repair process. Using a stress fracture
healing model, such as the rat ulna loading model (Bentolila 1998, Danova 2003, Tami 2003,
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Uthgenannt 2007b) we can study woven bone formation without the complexities involved in
fracture healing. Wohl et al. have shown early changes in expression of genes related to
angiogenesis and osteogenesis in stress fracture healing (Wohl 2009). Furthermore, the vascular
changes seem to correlate in a temporal and spatial pattern to the location of new bone formation
(Matsuzaki 2007). These findings suggest that angiogenesis is required for successful woven
bone repair.
Our objective was to determine the effects of angiogenic inhibition on woven bone
formation in the rat ulna following fatigue injury. We hypothesized that administration of TNP-470
1) restricts upregulation of angiogenic and osteogenic genes associated with woven bone
formation and 2) impairs vessel formation and blood flow. Furthermore, we hypothesized that
administration of TNP-470, SU5416 or YC-1 reduces woven bone area following fatigue loading
in the rat ulna.

4.4

Methods
The Washington University Animal Studies Committee approved all animal protocols.

4.4.1

Forelimb Loading
Male Fischer 344 rats (n=66, 5 mo) were anesthetized (isofluorane) and right forelimbs

were loaded in a single bout of cyclic (2 Hz) axial compression at a constant peak force (18 N) as
previously described (Uthgenannt 2007b). The left limb was not loaded and served as a control.
Force and displacement were continuously monitored (60 Hz; Labview). Fatigue injury was
controlled by limiting the cumulative maximal displacement to 65% (1.3 mm) of sub-fracture
displacement (Uthgenannt 2007b). After loading, rats were given an analgesic (0.03 mg/kg
buprenorphine) and returned to their cages. Rats were euthanized using CO2 at day 0 (1 hr), day
1, day 3 or day 7 following loading.

4.4.2 Delivery of Angiogenic Inhibition Drugs
All angiogenic inhibitors (or vehicle alone) were administered daily, with the initial dose
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prior to the start of loading. Injections were given up to, but not including, the day of euthanasia.

TNP-470
Animals were given TNP-470 (Seedhom) at a dose of 25 mg/kg s.c.. Vehicle animals
were given an equivalent volume of saline, with the first injection 1 hr prior to loading. Ulnae were
assessed for gene expression, blood vessel formation, blood flow (positron emission
tomography), or bone formation (Table 4.1).

Table 4.1. Sixty-six rats were assigned as shown for each time period after a single fatigue
loading event. PET imaging was performed serially on 3 rats per group at each time point. Day 0
measures were taken 1 hr after loading.
Outcome
(technique)
Gene Expression
(qRT-PCR)
Vessel Formation
(Microfil perfusion)
Blood Flow
(PET [15O] imaging)
Woven Bone Area
(dynamic histomorphometry)

TNP-470
Vehicle
TNP-470
Vehicle
TNP-470
Vehicle
TNP-470
Vehicle

Day 0
6
6
3
3
-

Rats per time period
Day 1
Day 3
Day 7
6
6
6
6
6
6
Æ
Æ
Æ
Æ
Æ
Æ
6
6

SU5416
SU5416 (Sigma) was given systemically (i.p. injection) at a dose of 12.5 mg/kg/day (Fong
1999). Vehicle rats were given an equivalent dose of dimethyl sulfoxide (DMSO; 350 µl/day).
Local injections were given in doses of either 50 µg/day or 500 µg/day in a 5 µl volume (DMSO or
inhibitor mixed into DMSO), injected into the forelimb near the periosteum on the medial side of
the ulna. Regardless of delivery methods, the first injection was given 10 minutes prior to loading.
Ulnae were assessed only for bone formation (n=2-4/gp) at day 7.

YC-1
Rats given treatment with YC-1 (Axxora) were administered injections following the same
protocols as SU5416. Daily i.p. injections were given at a dose of 30 mg/kg/day (Yeo 2003) while
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local injections were of either 50 µg/day or 500 µg/day (DMSO vehicle for all groups). The first
injection was given 10 minutes prior to loading. One rat given YC-1 (i.p. 30mg/kg/day) died on
day 3 due to injection complications and was excluded from the study. Ulnae were assessed for
bone formation (n= 2-4/gp) at day 7.

4.4.3

Gene Expression – Quantitative Real Time PCR
Changes in gene expression were assessed using quantitative real time PCR (qRT-PCR)

using recently described methods (Wohl 2009). Briefly, ulnae were dissected and immediately
placed into liquid nitrogen. A 5 mm section from the central ulna was pulverized and RNA
extracted (Qiagen). RNA quantity (Nanodrop) and quality (Agilent bioanalyzer) were assessed
before making cDNA (Superscript III; Invitrogen). Quantitative real time PCR was run using
validated primers (Wohl 2009) on two angiogenic markers, vascular endothelial growth factor
(Vegf) and platelet endothelial cell adhesion molecular (Pecam1). Additional osteogenic markers
were also evaluated, including bone morphogenetic protein 2 (Bmp2), osterix (Osx) and bone
sialoprotein (Bsp). Measures of real-time PCR cycle to threshold were normalized to the
expression of glyseraldehyde-3-phosphate dehydrogenase (Gapdh) for each ulna. To obtain a
fold change comparison between experimental groups, Gapdh-normalized expression from each
loaded ulna was divided by the normalized gene expression from the non-loaded contralateral
control (2-ΔΔCt).

4.4.4

Analysis of Vasculature
Vessel formation (day 3) was assessed by silicone rubber perfusion of the vasculature

followed by routine histology. Using this technique the vessels were easily visualized with the
surrounding tissue and cell morphology preserved. The methods have been recently described
(Matsuzaki 2007). Rats were anesthetized (87 mg/kg ketamine, 13 mg/kg xylazine, IP) and the
heart exposed via a thoracic incision before placing an 18- g catheter into the left ventricle.
Heparin (10 ml, 100 USP units/ml) was injected to inhibit clotting. Rats were then euthanized by
exsanguination. The vasculature was irrigated with saline prior to injection of a silicone rubber
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solution (MICROFIL® MV-122, Flow Tech). Specimens were cured overnight (4 ºC). The ulna
was dissected and processed for paraffin embedded histology. Sections (5 μm) were cut 1 mm
distal to the mid-diaphysis and were quantitatively assessed. Perfused vessels were segmented
from the rest of the image in order to calculate vessel number and total vessel area (Bioquant).

4.4.5

Positron Emission Tomography
To detect changes in blood flow, positron emission tomography (PET) imaging was

performed serially on days 0, 1, 3 and 7 using [15O] water. Imaging was performed on a
microPET-focus® system (Concorde Microsystems), by the Small Animal Imaging Core at
Washington University. Rats were anesthetized (1-3% isofluorane), positioned supine,
immobilized and injected with an IV bolus of 30-40 mBq of [15O] water. Dynamic PET data were
acquired for 5 min (2 sec × 15 frames, 3 sec × 10 frames, 5 sec × 12 frames, 10 sec × 6 frames,
30 sec × 4) for [15O] water. After imaging, rats were returned to their cages. Regions of interest
(Sirois) were drawn on both right and left forelimbs to calculate the standardized uptake value
(SUV) of tracer.

4.4.6

Bone Formation
To assess woven bone formation, rats were injected with calcein green (day 0) and alizarin

complexone (day 5) before being sacrificed on day 7. Ulnae were imaged using microCT (16 µm
resolution) and embedded in plastic (methylmethacrylate). Plastic embedded ulnar sections (100
micron, 1 mm distal to the mid-diaphysis) were analyzed for woven bone area using Bioquant.

4.4.6

Statistics
Data from loaded ulnae were compared to contralateral non-loaded ulnae using a paired t-

test (p<0.05). Comparisons between inhibitor and vehicle treatments were made by ANOVA (p <
0.05).
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4.5

Results

4.5.1

TNP-470
TNP-470 administration significantly diminished bone formation but did not affect

angiogenesis in the fatigue-loaded rat ulna. Bone formation measurements revealed a 60%
reduction in woven bone area after TNP-470 treatment (0.45 mm2) compared to vehicle alone
(1.15 mm2) (Figure 4.1). Additionally, the extent of woven bone (as measured along the length of
the ulna by microCT) was reduced (Figure 4.2). Vascular perfusion (Figure 4.3) and [15O] water
PET (Figure 4.4) demonstrated increased vascularity/blood flow in loaded forelimbs vs. controls,
but TNP-470 did not diminish these loading-induced changes. Osteogenic-angiogenic coupling
factors Bmp2 and Vegf were significantly upregulated vs. control at 1 hr along with endothelial
cell marker Pecam (Figure 4.5). All genes, including bone formation markers Bsp and Osx, were
significantly upregulated on days 1 and 3, regardless of treatment. TNP-470 did not effect gene
expression on day 0 or day 1, but expression of Pecam, Osx, and Bsp was significantly reduced
in TNP-470 vs. vehicle treated ulnae on day 3.

*

Figure 4.1. Administration of TNP-470 significantly reduced woven bone formation after fatigue
loading. (A) Rat ulna cross-sections labeled with calcein (green) and alizarin complexone (red)
show differences in periosteal woven bone formation. (B) Quantification of woven bone revealed
a reduction in bone area following treatment with TNP-470.
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*

Figure 4.2. Administration of TNP-470 significantly reduced woven bone extent after fatigue
loading. (A) MicroCT reconstructions of the central 14 mm of the rat ulna. (B) The woven bone
extent was significantly reduced following treatment with TNP-470.
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TNP-470

A)

B)

Vehicle

C)

Vessel
Area (mm)
Vessel
Area
50000

(mm2)

Vessel Number

Vessel Number

700
600
500
400
300
200
100
0

60000
40000
30000
20000
10000
0
TNP
Vehicle
TNP-470

Non-loaded

TNP
Vehicle
TNP-470

Vehicle
Right Ulna

Vehicle

Left Ulna

Figure 4.3. Vascularity was increased 3 days after loading. (A) H&E stained sections show
increased vessels for both TNP-470 and vehicle treatment groups compared to non-loaded
controls. (B,C) Vessel area and number are significantly increased after loading (compared to
non-loaded controls), but there was no significant change between treatment groups.
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*
*

Figure 4.4. Fatigue loading increased blood flow. The fold increase (loaded/non-loaded) in [15O]
water standard uptake value (SUV) was assessed by PET imaging. There were no significant
differences between TNP-470 and vehicle at any timepoint.
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(* p<0.05 loaded vs. control)

Figure 4.5. Gene expression significantly increased following fatigue loading. Fold increase in
gene expression was measured by qRT-PCR at day 0 (1 hr), day 1 and day 3. Angiogenic genes
Vegf and Pecam were significantly increased in both groups at all timepoints, but a treatment
effect was seen only at day 3 for Pecam expression. Expression of Bmp2 was unchanged by
treatment with TNP-470. Bone formation markers Osx and Bsp were significantly reduced on day
3 following treatment with TNP-470.
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4.5.2

SU5416 and YC-1
Treatment with VEGF inhibitor SU5416 or HIF1a inhibitor YC-1 did not reduce bone

formation following forelimb loading. Both systemic and local injections with either vehicle
(DMSO) or inhibition drug reduced body weight by more than 5% throughout the duration of the
experiment (Figure 4.6). Assessment of systemic injections by microCT demonstrated no change
in woven bone area or extent compared to vehicle treatment (Figures 4.7 and 4.8). In contrast,
local injections of both SU5416 and YC-1 dramatically increased woven bone formation (Figure
4.9). Additionally, local injection of vehicle (DMSO) increased woven bone extent, but
suppressed woven bone formation in localized areas along the medial side of the ulna.

B)

Figure 4.6. Animals treated with vehicle (DMSO), SU5416 or YC-1 lost weight during the
experiment. Animals were given (A) systemic injections or (B) local injections. Weight loss
peaked around day 4 or 5 for both types of injections. Systemic injection weight loss increased
with time whereas local injection weight loss was reduced between days 4 and 7. The animal
weight loss was less than 10% of total body weight. (n=3-4/group; *p<0.05 vs. YC-1; # p<0.05
vs. SU5416)
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Figure 4.7. Inhibition of angiogenesis using systemic injections of SU5416 or YC-1 did not affect
woven bone formation. The non-treated group was not different from vehicle (DMSO), SU5416 or
YC-1 treatment. (n=2-4/group; scale bar = 1 mm)

Figure 4.8. Total woven bone extent was not diminished following treatment with angiogenic
inhibitors SU5416 or YC-1. The woven bone extent for SU5416 treated animals was significantly
higher than those treated with YC-1, but treatment did not reduce woven bone extent compared
to vehicle (DMSO) or non-treated animals (n=2-4/group; *p<0.05 vs. YC-1)
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Figure 4.9. Local injections increased woven bone extent. Local injections of vehicle (DMSO),
SU5416 and YC-1 all increased the extent of woven bone to greater than 14 mm (total area
scanned). Vehicle treatment (with DMSO) diminished bone formation in some areas on the
medial surface of the ulna. Bone area increased with treatment of SU5416 and YC-1 compared
to non-treated controls. (n=2-4/group; scale bar = 1 mm)

4.6

Discussion
The objective of our study was to determine the effects of angiogenic inhibition on woven

bone formation in the rat ulna following fatigue injury. In partial agreement with our first
hypothesis, administration of the angiogenic inhibitor TNP-470 significantly impaired upregulation
of osteogenic genes Bsp and Osx and angiogenic marker Pecam on day 3. Contrary to our
second hypothesis, administration of TNP-470 did not inhibit vascular changes or blood flow
following fatigue loading. Third, we hypothesized that angiogenic inhibition would reduce woven
bone area. In agreement with this hypothesis, administration of TNP-470 impaired woven bone
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formation, however administration of SU5416 and YC-1 did not decrease bone formation.
Overall, our attempts to inhibit angiogenesis with the goal of reducing woven bone formation were
unsuccessful.
TNP-470 treatment prevented callus formation in fracture repair (Hausman 2001) and
bone formation in distraction osteogenesis (Fang 2005), which is similar to our results in stress
fracture healing. The increase in Pecam, Osx, and Bsp expression (on day 3) coincides with
periosteal thickening and onset of woven bone formation in this model (Silva 2006b, Wohl 2009).
TNP-470 inhibited Pecam staining (indicator of vascularity) on day 13 of distraction osteogenesis
(Fang 2005). In our study, the drop in Pecam expression in TNP-470 treated ulnae on day 3 is
consistent with inhibition of endothelial cell proliferation. The lack of effect of TNP-470 on growth
factors, Bmp2 and Vegf, is also consistent with the mechanism of action of TNP-470, suggesting
that TNP-470 acts downstream of both Vegf and Bmp2. Importantly, the drop in gene expression
for osteoblast signaling (Osx) and matrix formation (Bsp) and the reduction in woven bone area
on day 7 demonstrate a significant influence of TNP-470 on osteogenesis, with no affect on
angiogenesis.
VEGF is tightly coupled to vascularization and has been a popular target molecule in antiangiogenic research. Mice lacking VEGF exhibited delayed blood vessel invasion during
endochondral bone development (Maes 2002, Zelzer 2002). The early upregulation of Vegf and
Pecam in our study demonstrates a rapid vascular response to fatigue loading. SU5416, which
acts on VEGF, has been reported to reduce vessel density (Ma 2003). One difference between
administration of TNP-470 and SU5416 is the vehicle (PBS and DMSO, respectively). Treatment
with DMSO vehicle has had mixed results in prior tumor models, having no effect (Takamoto
2001), or reducing tumor volume compared to the control (non-treated) (Ma 2003). We saw no
vehicle affect with systemic treatment, but local injections reduced woven bone formation on the
medial side of the ulna (near the injection site). The anti-angiogenic activity of SU5416 has been
reported in vivo, but to our knowledge, has not been used with regard to a bone phenotype.
Unfortunately, in our model, administration of SU5416 did not reduce bone formation.
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HIF signaling is central to angiogenesis-osteogenesis coupling in osteoblasts, particularly
because it regulates VEGF (Berchner-Pfannschmidt 2008, Lohela 2009). Thus, inhibition of HIF
has been investigated as a potential cancer drug target (Liao 2007, Powis 2004, Shin 2007).
Because of this interest a variety of drugs, such as YC-1, have been produced that target HIF and
report a decrease in angiogenesis. Prior research has shown that YC-1 treatment leads to a
reduction in migration of cancer cells (Shin 2007), decreased expression of Hif1a and Vegf
(Powis 2004, Yeo 2003) and smaller, less vascularized tumors (Yeo 2003). To our knowledge,
no work has been done using YC-1 to inhibit bone formation. Similar to SU5416, we saw no
reduction in woven bone formation following administration of YC-1 in vivo.
One of the main limitations to this study was the potential lack of localization of the drug
to our target area, near the midpoint of the ulna. Although previous studies using other models
have shown the efficacy of systemic injections using the same angiogenic inhibitors, it was
possible that poor drug delivery played a role in the lack of anti-angiogenic response to loading.
An additional limitation to our study was drug dosing. The lack of vascular inhibition by TNP-470
may have been due to sub-optimal dosing or insufficient administration period. In order to limit the
amount of drug (and vehicle) the animal was exposed to, we used the lowest effective dose of
inhibitor published. Perhaps using a higher dose, as documented in other studies, we could have
suppressed angiogenesis. Finally, our local injections seemed to cause a reaction in the
periosteum not associated with loading. This technique needs to be improved in order to reduce
the injection effect on healing.
Further elucidation of the mechanisms that are responsible for osteogenesisangiogenesis coupling will deepen our understanding of bone development and homeostasis, and
it may also aid in the design of new therapies for accelerating bone regeneration and repair.

In

order to determine the importance of angiogenesis on woven bone formation we need to expand
our angiogenic inhibition work. This can be done with the use of different drugs, better drug
targeting or continuous drug delivery. We have shown that bone formation is a complex process
that cannot be stopped by inhibition of a single angiogenic target molecule.
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In conclusion, the angiogenic inhibitor TNP-470 impairs osteogenic gene expression and
dramatically reduces woven bone formation following fatigue loading. Use of VEGF inhibitor
SU5416 and HIF1a inhibitor YC-1 did not show any reduction in woven bone formation using
local or systemic deliveries. At this point in time we have yet to prove the angiogenic
dependence of woven bone formation.
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5

In vivo static creep loading of the rat forelimb reduces ulnar structural properties

at time-zero and induces damage-dependent woven bone formation

5.1

Abstract

Periosteal woven bone forms in response to stress fractures and pathological overload. The
mechanical factors that regulate woven bone formation are poorly understood. Fatigue loading of
the rat ulna triggers a woven bone response in proportion to the level of applied fatigue
displacement. However, because fatigue produces damage by application of cyclic loading it is
unclear if the osteogenic response is due to bone damage (injury response) or dynamic strain
(adaptive response). Creep loading, in contrast to fatigue, involves application of a static force.
Our objectives were to use static creep loading of the rat forelimb to produce discrete levels of
ulnar damage, and subsequently to determine the bone response over time. We hypothesized
that 1) increases in applied displacement during loading correspond to ulnae with increased crack
number, length and extent, as well as decreased mechanical properties; and 2) in vivo creep
loading stimulates a damage-dependent dose-response in periosteal woven bone formation.
Creep loading of the rat forelimb to progressive levels of sub-fracture displacement led to
progressive bone damage (cracks) and loss of whole-bone mechanical properties (especially
stiffness) at time-zero. For example, loading to 60% of fracture displacement caused a 60% loss
of ulnar stiffness and a 25% loss of strength. Survival experiments showed that woven bone
formed in a dose-dependent manner, with greater amounts of woven bone in ulnae that were
loaded to higher displacements. Furthermore, after 14 days the mechanical properties of the
loaded limb were equal or superior to control, indicating functional repair of the initial damage.
We conclude that bone damage created without dynamic strain triggers a woven bone response,
and thus infer that the woven bone response reported after fatigue loading and in stress fractures
is in large part a response to bone damage.

5.2

Key Terms
Bone fatigue; bone creep; bone damage; rat ulna; in vivo forelimb loading
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5.3

Introduction
Repetitive loading of bone causes fatigue, characterized by the formation and

propagation of cracks and the progressive loss of strength and stiffness (Carter 1977, Pattin
1996). Bone fatigue can lead to stress fractures, which are common in athletes and military
recruits (Beck 1996, Shaffer 2001). Histologically, stress fractures are associated with localized
intracortical remodeling and periosteal woven bone formation (Johnson 1963, Mori S 2001),
findings that are also observed in the rat ulna after a bout of damaging fatigue loading (Bentolila
1998, Hsieh 2002, Tami 2003).
The factors that contribute to fatigue-induced woven bone formation are poorly
understood, although recent studies using the rat ulna loading model have examined this issue.
In this model, dynamic compressive (fatigue) loading is applied to the forelimb, causing bending
of the ulna leading to gradients in mechanical strain (Kotha 2004). Peak strains are located on
the medial (compressive) surface, 1-3 mm distal to the midpoint of the ulna, corresponding with
sites of fatigue crack formations (Danova 2003, Tami 2003, Uthgenannt 2007b) and maximal
woven bone formation (Kotha 2004). Woven bone formation is stimulated in areas of high strain
(Bentolila 1998, Kotha 2004, Tami 2003). Recently, we used this model to produce discrete
levels of ulnar damage in vivo by controlling the level of peak displacement applied during fatigue
loading (Uthgenannt 2007b). We observed that 7 days after loading, there was a dose-response
in the area of new periosteal woven bone formation, where the amount of new bone was
proportional to the level of imposed damage (Uthgenannt 2007a). This finding suggests that the
woven bone response to fatigue loading is damage-dependent. However, because fatigue
produces damage by application of dynamic loading, it is unclear if the osteogenic response is
due to the effects of bone damage or to direct effects of dynamic strain.
Creep loading, in contrast to fatigue, involves application of a static force. As with fatigue
loading, bone can sustain progressive displacement and damage under creep loading (Caler
1989, Carter 1985). Thus, static creep loading is a method that can be used to produce bone
damage without dynamic loading and thereby provides a useful experimental tool to separate the
effects of these two osteogenic stimuli. While non-damaging static loading is generally believed
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to be non-osteogenic (Lanyon 1984, Robling 2001b), to our knowledge the response of bone to
creep loading that produces measurable bone damage has not been reported.
Our objectives were to use static creep loading of the rat forelimb to produce discrete
levels of ulnar damage, and subsequently to determine the in vivo bone response to creep
damage. By analogy to the results of recent fatigue experiments (Uthgenannt 2007a, Uthgenannt
2007b), we hypothesized that 1) increases in applied displacement during loading correspond to
ulnae with increased crack number, length and extent, as well as decreased mechanical
properties; and 2) in vivo creep loading stimulates a damage-dependent dose-response in
periosteal woven bone formation.

5.4

Methods
The forelimbs of 134 adult (4 ½ - 5 ½ month old) male Fischer 344 rats (Zimmerman)

were loaded in axial compression based on an established rat forelimb loading model (Bentolila
1998, Hsieh 2002, Tami 2003, Uthgenannt 2007b), except rather than applying cyclic loading we
applied static loading. Rats were anesthetized using 1-3% isoflorane and loading was applied
across the carpus and olecranon process using a servohydraulic materials testing machine
(Instron 1321/8500R or 8841). After application of a 0.3 N preload, a force-controlled single ramp
(ramp time: 0.25 s) was applied to a pre-determined force level, which was then held constant.
Force and displacement data were recorded at 30 Hz (LabView 7.0). In an initial experiment,
right and left forelimbs (n = 35) from 18 rats were creep loaded to failure at peak forces between
17 and 30 N. The creep curves were consistent with previous descriptions of bone creep
behavior (Figure 5.1). Time to failure (tf; minutes) correlated moderately well with force (F;
newtons): F = -1.64Log(tf) + 25.0 (r2 = 0.66, p < 0.05). The peak force necessary to cause failure
after an average of 1 hour of loading was estimated from the force-time to failure equation.
Importantly, forelimbs fractured reproducibly (independent of force magnitude or time to failure)
when the displacement increased by 2.32 ± 0.46 mm compared to the displacement at 5
seconds.
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Figure 5.1. Representative creep curves as a function of normalized time. The force is ramped
up within 0.25 seconds and held constant for the duration of the test. Displacement changes
after 0.25 seconds are considered to be creep displacement. The test shown here ended when
fracture occurred (at 6.9 min). The relative actuator position tracks the displacement through
three stages of creep (Bowman 1994, Caler 1989, Carter 1977). The primary stage has an initial
rapid increase in creep displacement followed by gradually decreasing slope. The secondary
creep stage follows with a relatively constant creep rate. The tertiary creep stage begins with a
rapid acceleration in creep rate leading to fracture. The average displacement to fracture was
2.32 ± 0.46 mm relative to the displacement at 5 seconds. Five seconds was used as a
reference time to match the reference time used in our previous fatigue studies (Uthgenannt
2007b). Displacement in the first 5 seconds of the test is attributed to elastic deformation of the
forelimb and soft tissue creep. In subsequent sub-fracture experiments, actuator displacement
was monitored and stopped at a percentage of the average fracture displacement.

The right forelimbs of the remaining rats were loaded until the displacement reached a
target value less than the average displacement to fracture. Left limbs were not loaded and
served as controls. The force applied to the right forelimbs was between 17.3-19.8 N (although
constant for each rat; avg. 18.9 ± 0.7 N) resulting in average loading times less than 1 hour.
Based on previous strain gage data, these forces were expected to generate initial compressive
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strains of 2330 – 2660 με. During loading of approximately one-half of the forelimbs, there were
small sinusoidal variations in applied load (0.1 Hz, ±0.1 N) due to servo controller error.
Subsequent strain gage tests were performed on three post mortem specimens; full methods
were described previously (Uthgenannt 2007b). Briefly, strain gages (SS-080-050-500P-SI;
Micron Instruments) were attached near the midpoint of the ulna and the forelimb was creeploaded. Fluctuations in strain corresponding to the small sinusoidal variations in applied load
were recorded. Results indicated that the peak-to-peak strain associated with these variations
was < 20 microstrain, or < 1% of the total ulnar strain. For pain relief after loading, rats were
administered an intramuscular injection of Buprenex (1.67 mg/kg buprenorphine hydrochloride).
All rats were euthanized by CO2 asphyxiation on day 0, 7 or 14 according to their experimental
group. This study was approved by our institutional Animal Studies Committee.

5.4.1

Loading-Induced Damage
Seventy-four rats were used to investigate the effects of a single bout of creep loading on

ulnar crack formation and mechanical properties. Rats were assigned to eight sub-fracture
displacement groups (20, 30, 40, 50, 60, 70, 80 and 90%; n = 7-11 per group). Right forelimbs
were loaded until the displacement reached the prescribed stopping displacement (X% of the
average displacement to fracture). Forelimbs of two rats fractured during loading and they were
excluded from the study. The loading time ranged from 0.22 min (a rat from the 20%
displacement group) to 192.5 min (a rat from the 50% displacement group) (Table 5.1). Rats
were euthanized immediately after loading.
Micro-computed tomography (microCT, Scanco Medical μCT40) was used to image and
characterize cracks in excised ulnae before mechanical testing. The middle one-third of the ulna
was scanned at 16 μm resolution (55 kVp, 172 mA, 200 ms) perpendicular to the long axis of the
bone. First, the ulnae were assessed for presence of a crack. The overall crack extent (Cr.E)
was measured along the length of the bone as the distance between the first and last transverse
CT slice where the crack appeared. The position of the midpoint of the crack relative to the
midpoint of the bone was calculated. Finally, using the manufacturer’s software (Eval v5.0) a
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single user determined the crack number density (Cr.N.D) and length density (Cr.L.D), averaged
over four evenly spaced CT slices spanning the crack region.
The mechanical properties of loaded ulnae and non-loaded controls were assessed using
three-point bending (Instron 8841). Ulnae were positioned on supports 15 mm apart and the
displacement was applied on the medial surface at the midpoint of the ulnar length, producing
bending in the same plane as during axial compression. A 0.5 N preload was manually applied
followed by a 0.5 mm/s ramp to failure. Standard structural properties were determined from
force-displacement curves (Labview 7.0). Ultimate force was calculated as the peak force;
stiffness was calculated as the slope of the curve between 25 and 75% of the ultimate force; postyield displacement was calculated as the displacement from the yield point to the fracture point;
fracture energy was calculated as the area under the curve up to the fracture point.

5.4.2

Bone Formation Response
To investigate bone formation after damaging creep loading, survival rats (n=10/group)

were assigned to three sub-fracture displacement groups: low (20% of the average displacement
to fracture), medium (40%) or high (80%) displacement. The average loading times for the three
displacement groups were 1.08 ± 0.4, 9.58 ± 9.4 and 42.12 ± 50.5 minutes, respectively. Rats
were given intraperitoneal injections of 5 mg/kg calcein green (Sigma) on day 0 and 30 mg/kg
alizarin-complexone (Sigma) on day 5 before being euthanized on day 7. The excised ulnae
were imaged using microCT to discern cracks and calculate woven bone extent before being
embedded in plastic and sectioned for histology.
Bone area (B.Ar) and bone mineral density (BMD) (calibrated to the manufacturer’s
hydroxyapatite (HA) mineral phantom) were determined using microCT. Analysis was performed
at eight locations spaced longitudinally along the bone from 6 mm proximal to the midpoint (P6) to
8 mm distal to the midpoint (D8) in 2 mm intervals. Using manufacturer’s software an average of
six CT slices (96 μm total) at each location were analyzed for bone area and BMD (images
manually segmented by a single user). Bone mineral content (BMC) was calculated as BMC =
B.Ar × BMD. Ulnae were also analyzed for the presence of a visible crack and woven bone. If
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woven bone was present, the extent was computed by determining the beginning and ending CT
slices where woven bone was visible. The density of the woven bone at the midpoint was
computed for a subset of specimens (n=5).
Ulnae were then embedded in plastic (methylmethacrylate, Sigma) using standard
procedures in preparation for measurement of bone formation parameters. Sections (100 µm
thick) were cut at five locations along the length of the ulna from 5 mm proximal to the midpoint
(P5) to 7 mm distal to the midpoint (D7) in 3 mm intervals using a diamond-tipped saw microtome
(Leica Microsystems, SP 1600). Each section was mounted on a glass slide and visualized on an
inverted microscope with a 100 W mercury-halogen light source at a 4x objective (DP-30,
Olympus). Calcein was imaged using a fluorescein isothiocyanate (Jacobsen) filter, while alizarin
was imaged using a tetramethylrhodamine isothiocyanate (TRITC) filter. The images were
overlaid using camera software (Olympus). The sections were analyzed (ImageJ) by a single
user for woven bone area (Wo.B.Ar), bone area and labeled surfaces, including single-labeled
surface, double-labeled surface and woven bone-labeled surface. Contralateral ulnae were
pooled from each displacement group (n=4/group; 12 total) to form a common control group.

5.4.3

Recovery of Mechanical Properties
The recovery of mechanical properties was examined 14 days after loading. Rats (n=12)

were loaded to high displacement (80% of the average displacement to fracture) and then
allowed free cage activity for 14 days before being euthanized. The average loading time was
52.95 ± 35.4 minutes. Ulnae from nine rats were available for mechanical testing, as one
forelimb did not reach the necessary displacement within the 3-hour time limit and two forelimbs
fractured during loading. Excised ulnae were imaged using microCT before mechanical testing.
Identical to the time-zero experiment, the mechanical properties of the loaded and control ulnae
were assessed using three-point bending.
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5.4.4

Statistics
Differences between right and left ulnae were assessed using paired t-tests, while one-

way analysis of variance (ANOVA) was used to compare differences between displacement
groups. Significance was defined at P<0.05.

5.5

Results

5.5.1

Loading-Induced Damage
Static creep loading of the forelimb created ulnar cracks visible on microCT at time-zero.

Each displacement group had examples of loaded ulnae with visible cracks (usually one per
ulna), in addition to ulnae with no visible cracks (Table 5.1). The average crack (including all
displacement groups) was centered 0.11 ± 0.88 mm distal to the midpoint of the ulna. Generally,
crack extent and crack length density increased with increasing displacement, with greater values
in the 80 and 90% displacement groups than in most of the lower displacement groups. Left
ulnae served as controls and did not have any visible cracks.

79

Table 5.1. Time-zero crack parameters of loaded (Right) ulnae measured using microCT (mean
± SD; n=7-11/group). The displacement groups were determined as a percentage of the average
displacement to fracture (2.32 mm). Each displacement group had examples of ulna with a
visible crack, although no group had a visible crack in every ulna.

Displacement
Group

Loading
Time (min)

Visible
crack (%
of ulnae)

Crack extent
(mm)

Cr.L.D (mm/mm2)

Cr.N.D. (#/mm2)

Crack
midpoint1
(mm)

20%

1.05 ± 0.6

22

0.34 ± 0.19

0.32* ± 0.03

0.62* ± 0.04

0.30 ± 1.01

30%

6.65 ± 9.9

33

0.74* ± 0.38

0.47* ± 0.15

0.60* ± 0.03

0.02 ± 0.40

40%

19.33 ± 25.3

44

1.07* ± 0.66

0.58* ± 0.11

0.62* ± 0.07

0.08 ± 0.97

50%

54.21z ± 65.8

45

0.52 ± 0.32

0.33*c ± 0.09

0.60* ± 0.06

0.29 ± 1.21

60%

17.49 ± 18.1

66

0.58 ± 0.29

0.54*d ± 0.19

0.64* ± 0.05

0.64 ± 0.80

70%

17.78 ± 15.8

56

0.92* ± 0.31

0.64*ad ± 0.11

0.61* ± 0.07

-0.52e ± 0.82

80%

10.04 ± 10.9

71

1.18*ade ± 0.43

0.75*abde ± 0.11

0.76*bcdef ± 0.08

0.21 ± 0.93

56

1.32*ade

0.74*abde

90%

9.19 ± 14.2

± 0.61

± 0.26

0.78*abcdef

± 0.17

-0.21 ± 0.78

P<0.05: * vs. zero; a vs. 20%; b vs. 30%; c vs. 40%; d vs. 50%; e vs. 60%; f vs. 70%; z vs. all displacement groups
1The crack midpoint was measured in the distal direction from the midpoint of the ulna; negative midpoint values are proximal
to the ulna midpoint.

Static creep loading caused degradation of ulnar mechanical properties. Three-point
bending tests revealed significant reductions in ulnar stiffness (loaded (Right) compared to control
(Left)) in displacement groups higher than 20% (Figure 5.2). For example, forelimbs loaded to
60% of fracture had a 60% loss of ulnar stiffness. Beyond 60% displacement there were no
further reductions in stiffness. There were similar reductions in ultimate force, although of less
magnitude (Table 5.2). Post-yield displacement and energy to fracture did not display a clear
decreasing trend with higher displacement groups. Notably, reductions in mechanical properties
were observed in both loaded ulnae with and without visible cracks on microCT.
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Figure 5.2. Increasing displacement caused progressive loss of time-zero bone stiffness. (The
percent change in stiffness for loaded (R) versus control (L) limbs was calculated using (RL)/L*100.) For all displacement groups beyond 20%, loaded ulnae were significantly less stiff
than controls. Beyond 60% displacement there were no further reductions in stiffness. (P<0.05: *
vs. control; a vs. 20%; b vs. 30%, 40% and 50%)

Table 5.2. Time-zero mechanical properties of isolated ulnae determined using three-point
bending after in vivo creep loading of the right forelimb (mean ± SD; n=7-11/group). Data from
the loaded (Right) limbs and control (Left) limbs were evaluated.

Displacement
Group
20%
30%
40%
50%
60%
70%
80%
90%

Stiffness (N/mm)
Left
19.8 ± 3.4
20.9 ± 1.8
21.0 ± 2.1
21.3 ± 2.3
22.2z ± 2.9
22.1z ± 2.1
21.1 ± 1.7
21.5 ± 2.3

Right
16.9 ± 4.8
14.9* ± 4.2
12.8*a ± 3.8
13.9* ± 3.5
8.90*abcd ± 2.5
9.86*abd ± 2.3
7.27*abcd ± 1.9
8.06*abcd ± 2.4

Ultimate force (N)
Left
13.3 ± 1.1
13.5 ± 1.1
13.3 ± 1.0
13.5 ± 1.3
13.8 ± 1.4
13.6 ± 1.0
13.5 ± 1.1
13.4 ± 0.82

Right
12.8 ± 1.6
12.6 ± 1.5
11.9 ± 1.4
12.7 ± 1.7
10.3*abcd ± 1.8
11.1*abd ± 1.0
10.3*abd ± 1.2
10.6*abd ± 1.9

Fracture energy (Nmm)
Left
19.7 ± 3.1
24.3z ± 5.2
24.0 ± 3.8
24.7z ± 6.1
23.4 ± 3.0
22.5 ± 4.6
24.4z ± 4.3
23.4 ± 6.3

P<0.05: * vs. control; a vs. 20%; b vs. 30%; c vs. 40%; d vs. 50%; z vs. 20% control group

81

Right
20.7 ± 4.2
19.0 ± 3.8
18.1* ± 6.2
21.4 ± 5.7
14.7*ad ± 5.6
14.2*ad ± 5.9
15.3*d ± 4.8
17.3 ± 6.5

Post-yield displacement (mm)
Left
1.24 ± 0.26
1.66z ± 0.55
1.63z ± 0.27
1.68z ± 0.46
1.51 ± 0.19
1.47 ± 0.29
1.63z ± 0.27
1.58 ± 0.48

Right
1.35 ± 0.28
1.18 ± 0.31
1.12* ± 0.48
1.39 ± 0.51
0.90d ± 0.57
0.79*ad ± 0.58
0.82*ad ± 0.50
1.07 ± 0.62

5.5.2

Bone Formation Response
Micro-computed tomography of loaded ulnae 7 days after loading revealed a

displacement-dependent woven bone response (Figure 5.3a, Table 5.3). Total woven bone area
(summed over five histomorphometry sections) increased progressively and was significantly
different between each of the displacement groups (Figure 5.3b). The same results were seen
for woven bone extent. Woven bone was absent from all control specimens.

A
A

20% displacement

40% displacement

2
Woven Bone Area (mm2)

B

80% displacement

a,b
*

1.5
a
*

1
0.5
00
20
20%

40
40%

80
80%

Creep Displacement (% of fracture displ.)
Figure 5.3. A clear dose-response was seen in the total amount of woven bone formed after
creep loading. (A) Histological and microCT images illustrate increasing amounts of periosteal
woven bone formation 1 mm distal to the midpoint of the bone for low (20%), medium (40%) and
high (80%) displacement groups. (B) Quantification of woven bone area (totaled from all
histomorphometry slides at five locations) demonstrates significant differences between
displacement groups. (P<0.05: * vs. control; a vs. 20%; b vs. 40%)
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Table 5.3. MicroCT (n=5-10/group) and histological (n=8-10/group) parameters (mean ± SD)
measured 7 days post loading. The last four parameters (BMC, B.Ar, Wo.B.Ar and LS/BS) were
measured 2 mm proximal to the midpoint of the ulna. The loaded (Right) ulnae are compared to
a pooled control (Left) ulnae group.
Displacement
Group

Visible Crack
(% of ulnae)

Visible Wo.B.
(% of ulnae)

Wo. B. Extent
(mm)

BMC (mg/cm)

B.Ar (mm2)

Wo.B.Ar
(mm2)

LS/BS
(%)

Control

0

0

0.00 ±0.00

1.85 + 0.09

1.74 + 0.06

0.00 ±0.00

66 ±17

20%

0

30

0.37 ±0.88

1.85 ±0.05

1.79 ±0.04

0.00 ±0.00

89* ±9

3.70*a

40%

50

90

80%

80

100

±1.7

5.25*ab ±0.98

2.01*a

±0.17

2.25*ab ±0.29

2.11*a

±0.33

2.71*ab ±0.65

0.10*a

±0.13

92* ±8

0.18*a ±0.12

96* ±4

P<0.05: * vs. control; a vs. 20%, b vs. 40%

Woven bone formed near the midpoint of the ulnae in each of the three displacement
groups. Sections taken 1 mm distal to the midpoint (D1) showed a clear dose-response with
progressively larger amounts of woven bone in proportion to initial displacement. The doseresponse at P2 was similar to that of D1, but without a significant increase from medium to high
displacement (P = 0.053). Furthermore, there was a dose-response in woven bone labeled
surface at D1 and P2. MicroCT data confirmed the changes in woven bone area seen using
histology.
The distribution of bone formation varied along the length of the ulna (Figure 5.4). The
largest amount of woven bone formed in the area of highest strain (Kotha 2004), near the
midpoint (MP) of the ulna. Bone mineral content and mineral density were significantly different
from control at the midpoint and 2 mm proximal to the midpoint (P2) for the 40 and 80%
displacement groups (data not shown). Outside of the region of high strain (away from the
midpoint) woven bone transitioned into lamellar bone. Woven bone was absent in sections 5 mm
proximal to the midpoint (P5) and comprised less than 1% of the total bone area at sections 4 and
7 mm distal to the midpoint (D4 and D7, respectively). Loaded ulnae (from all displacement
groups) had significantly more labeled surface compared to controls at all locations with the
exception of the low displacement group (20% displacement) at P5. In the low displacement
group there were no significant changes in BMC or BMD over the entire region of interest (P6D8).
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Figure 5.4. The magnitude and type of bone formed in response to creep loading varies
longitudinally, similar to the pattern observed after fatigue loading (Uthgenannt 2007a). (Data
from 40% displacement group shown; other groups had similar distributions) (A) The percentage
change in BMC peaks at the midpoint (MP) and decreases both in the proximal and distal
directions away from the midpoint. (B) Histological images illustrate labeled surfaces at five
locations along the ulna. Woven bone is greatest 1 mm distal to the midpoint (D1) on the medial
side of the bone. (P<0.05: * vs. control; a vs. D8; b vs. D6; c vs. D4; d vs. D2; e vs. MP; f vs. P2)

5.5.3

Recovery of mechanical properties
Ulnae from forelimbs loaded to high (80%) displacement demonstrated improvement in

several mechanical properties compared to controls at 14 days (Table 5.4, Figure 5.5). Threepoint bending tests revealed that the loaded ulnae had significantly greater values of ultimate
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force, post-yield displacement and fracture energy than control. The stiffness of loaded limbs
recovered to the level of control. Micro-computed tomography data showed visible cracks in 8
out of 9 ulnae. The woven bone density significantly increased between 7 and 14 days (7 days:
394 ± 21.5 mg HA/mm3; 14 days: 710 ± 32 mg HA/mm3; P < 0.0001), while woven bone extent
was unchanged (7 days: 5.25 ±0.98 mm; 14 days: 5.34 ±0.94 mm; P = 0.84).

Table 5.4. Day 14 mechanical properties of isolated ulnae determined using 3-point bending after
in vivo creep loading of the right forelimb (mean ± SD; n = 9). There were significant increases in
the loaded (Right) ulnae in ultimate force, fracture energy and post-yield displacement compared
to control (Left). (*p<0.05 vs. control)
Displacement
Group
80%

Stiffness (N/mm)

Ultimate force (N)

Fracture energy (Nmm)

Post-yield displacement
(mm)

Left

Right

Left

Right

Left

Right

Left

Right

23.9 ± 2.9

24.5 ± 3.7

14.9 ± 1.6

19.2* ± 1.5

21.1 ± 3.4

33.9* ± 6.0

1.2 ± 0.2

1.6* ± 0.3

Ultimate
force (N)
p<0.05

Stiffness
(N/mm)

Percent Change vs. Control

80
60

*

p<0.05

40
20
0
-20
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Figure 5.5. Initial significant decreases in stiffness and ultimate force were recovered 14 days
after loading. Percentage change is based on comparison to contralateral controls. There were
significant increases over the 14 day recovery period in both of these parameters. The ultimate
force of the loaded (Right) limb was significantly higher compared to control (Left) at 14 days post
loading. (*P<0.05 vs. control)

85

5.6

Discussion
Our objectives were to use static creep loading of the rat forelimb to produce discrete

levels of ulnar damage and subsequently to determine the in vivo bone response to creep
damage. In support of our first hypothesis, microCT and mechanical testing indicated that a
single bout of creep loading can lead to reduced structural properties at time-zero. Generally,
increased displacement produced a higher percentage of visible cracks, along with increased
crack length and extent and greater loss of stiffness. In support of our second hypothesis, creep
damage stimulated a dose-response in woven bone formation. This woven bone response led to
an enhancement of mechanical properties 14 days after loading. These findings demonstrate
that even without dynamic strain, bone damage triggers a woven bone response that leads to a
functional repair of whole-bone strength.
Previous studies of bone response to creep loading have reported mixed findings.
Positive osteogenic effects associated with static loading were reported in dog femora (Meade
1984) and rabbit calvariae (Hassler 1980). These studies both used long term loading protocols
that involved invasive surgical procedures to implant continuous loading devices. The bone
growth seen in these models could be due to an injury response, rather than an adaptation
response (Hassler 1980). Our study produced an osteogenic response using a short-term noninvasive, damaging loading protocol. More commonly, studies have shown no osteogenic
response to static loading, although these studies used loading protocols that probably did not
produce bone damage. Comparisons between static versus dynamic loading protocols applied to
the rabbit tibia (Hert 1969), the turkey ulna (Lanyon 1984) and the rat ulna (Robling 2001b)
demonstrated that static loading produced no osteogenic response whereas dynamic loading was
osteogenic. In growing rats, brief-duration static loading had an inhibitory effect on appositional
bone formation while dynamic loading triggered an adaptive formation response (Robling 2001b).
In addition, dynamic loading did not stimulate bone formation at frequencies below 0.5 Hz in the
rat tibia (Turner 1994a). Our findings clearly demonstrate that when static loading produces
measurable bone damage, woven bone formation is activated. While we also observed lamellar
bone formation, this occurred between sites where woven bone was activated and sites where
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there was no response. We hypothesize that this lamellar formation is part of a coordinated
damage response rather than a primary response to short-term static loading.
Creep displacement is a component of the total displacement that occurs during fatigue
loading in cortical (Carter 1985, Cotton JR 2005) and trabecular (Bowman 1998) bone.
Moreover, it is well established that static loading by itself leads to progressive creep of bone
(Bowman 1994, Caler 1989). While there are several reports on the degradation of bone
mechanical properties during fatigue (dynamic) loading both in vivo and ex vivo, with reported
decreases in modulus (Pattin 1996), strength (Carter 1977) and stiffness (Carter 1977, Danova
2003, Uthgenannt 2007b), similar data for in vivo creep (static) loading are lacking. Fondrk et al
(Fondrk 1988) demonstrated bone stiffness degradation during tensile creep, but they used
multiple cycle tests. Our results indicate that while creep loading of the rat ulna often produced
visible cracks on microCT (i.e., a stress fracture) and reductions in mechanical properties, there
were important differences between creep and fatigue damage. (Note that these comparisons
are being made between studies done in the same lab, using the same age and sex of rats, and
the same microCT and mechanical testing protocols. In both studies actuator displacement was
used to produce discrete levels of damage based on a percentage of the displacement to
fracture.) Fatigue loading more consistently created ulnar cracks that were visible on microCT
(Uthgenannt 2007b), whereas creep-loaded ulnae did not always have a visible crack even at
high values of displacement. Overall, there were fewer cracks and lower crack length density for
creep compared to fatigue loading. Reductions in ultimate force, although significant for creep
loading, were smaller than those reported for fatigue loading (P<0.001) (Uthgenannt 2007b). The
two types of loading produced similar reductions in stiffness, and in both cases stiffness loss was
detected in the absence of large cracks. We hypothesize that diffuse damage or cracks not
visible at 16 μm resolution contribute to the loss of stiffness in both creep and fatigue. We further
hypothesize that the loss of strength (ultimate force) is more strongly related to the formation of
large cracks than to diffuse damage or microcracks. In summary, creep and fatigue loading of
the rat ulna both produce bone damage but there are some notable differences between the two
loading models.
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Our motivation for examining the response of bone to damaging creep loading was to
follow up on previous studies that showed woven bone formation after damaging fatigue loading
(Colopy 2004, Hsieh 2002, Tami 2003, Uthgenannt 2007a). Consistent with fatigue loading
(Uthgenannt 2007a), there is a dose-response in woven bone formation after creep loading
whereby woven bone area increases with increasing damage. This strongly suggests that the
damage component of fatigue is the predominant stimulus for the woven bone formation we and
others have observed. Direct comparisons between the amount of woven bone formed for
fatigue versus creep are difficult because of the differences in damage between the two loading
modes as discussed above. Nonetheless, some qualified comparisons are worth considering.
The “low” (20%), “medium” (40%) and “high” (80%) creep displacement groups were chosen for
the survival experiments in this study because they produced equivalent loss of stiffness as the
30, 45 and 65% fatigue displacement groups (Uthgenannt 2007b) (~15, 40 and 60% loss of ulnar
stiffness, respectively). If stiffness loss is taken as the measure of structural damage, our data
indicate that creep produced a diminished woven bone response compared to damage-equivalent
fatigue loading. The center of woven bone formation was similar between the two loading modes,
at the ulnar midpoint (creep) or 1 mm distal to the midpoint (fatigue). Yet microCT analysis
revealed consistently less woven bone extent for bones loaded in creep – 4 mm shorter (92%
decrease) for the low-displacement group, and 2 mm shorter (35% and 25% decrease) for the
medium- and high-displacement groups. In addition, total woven bone area (summed over five
histology slides from P5 to D7) was reduced 94, 59 and 27% compared to fatigued loaded ulnae
for low, medium and high displacement groups, respectively. By day 14 the mechanical
properties of ulnae loaded in creep had recovered, similar to the response to fatigue loading
(Colopy 2004, Hsieh 2002, Uthgenannt 2007a), indicating a functional repair of the structural
damage in both cases. There are two possible explanations for the relatively greater woven bone
formation after fatigue loading compared to creep. First, the more severe crack formation in
fatigue may have stimulated a greater repair response. Second, the dynamic strain that occurs
with fatigue may have an additive effect on top of damage. The latter possibility is consistent with
the fact that supraphysiological levels of strain can stimulate woven bone formation in the
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absence of damage (Turner 1994a), and the likelihood that the dynamic strain in the region of
fatigue damage is supraphysiological.
There are several limitations to this study. First, our servohydraulic loading machines did
not always hold a constant force when the forelimb was displacing (creeping) slowly. Thus,
during creep loading, some forelimbs experienced a small, superimposed sinusoidal variation in
strain (less than 1% of the total strain). We do not believe this influenced the creep response, as
mouse forelimbs statically loaded with superimposed vibration were not stimulated to form new
cortical bone (Castillo 2006), and the frequency of the superimposed variation (0.1 Hz) is less
than that required to stimulate an adaptive bone response (Turner 1994a). Second, the applied
force was not equal for all animals. We found there were variations between different batches of
rats and the time it took them to reach their pre-determined displacement, so we adjusted the
force magnitude in an attempt to keep loading time in a target range of 10-60 minutes. Although
this may have added variance to our data, post hoc statistical analysis revealed no force
dependence on any of the parameters of interest. Third, it is possible that dynamic strain
produced during normal cage activities in the days following the bout of creep loading may have
contributed to the bone formation response. Future studies are planned to examine this
possibility. Fourth, the resolution of microCT is not high enough to detect true microcracks nor
can it detect diffuse damage. Additional studies are needed to better characterize and distinguish
the microdamage associated with creep versus fatigue loading. Finally, the bone formation
response and mechanical property assessment tests were not run at both 7 and 14 days.
Previous work in our lab has demonstrated that the total woven bone area does not increase from
7 to 14 days (Uthgenannt 2007a), thus 7 days is a suitable time to characterize bone formation.
Moreover, full recovery of mechanical properties after fatigue loading takes 12-14 days (Hsieh
2002, Uthgenannt 2007a); thus we chose 14 days to assess mechanical properties.
The results of our study may have clinical implications. We have demonstrated that
creep loading can lead to progressive bone damage, which suggests that the accumulation of
bone microdamage with age (Schaffler 1995) or disease may not be entirely due to dynamic
loading. Static loading, especially in the axial skeleton, may contribute importantly to bone
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deformation and damage, as has been suggested previously (Bowman 1994). Regardless of the
mechanical loading history that produces damage, our results indicate that when the damage
leads to measurable structural degradation, a woven bone repair response is activated.
In summary, creep loading results in decreased mechanical properties at time-zero and a
robust woven bone response 7 days after loading. We observed a clear dose-response with
progressively larger amounts of woven bone in proportion to initial creep displacement (damage).
This study provides an assessment of the bone damage response in the (near) absence of
dynamic strain. Comparisons between creep and fatigue demonstrate that the effects of creep
loading are similar to fatigue loading. We conclude that the woven bone response seen after the
creation of a stress fracture is largely a response to localized bone damage.
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6

Conclusions
Mechanical loading is a powerful osteogenic stimulus and can be used to initiate woven

or lamellar bone formation. The rat forelimb loading model applies a controlled waveform that
distributes high magnitude compressive and tensile strains on the medial and lateral surfaces of
the ulna, respectively. The changes in the strain environment, perhaps coupled with increased
fluid flow in the bone increase periosteal bone formation. By controlling the applied waveform,
the loading can be damaging or non-damaging to the structure of the bone. Thus, in a singlebout of loading we can stimulate formation of woven or lamellar bone near the ulnar midpoint.
The synchronization of the timelines between damaging and non-damaging loading
protocols allowed us to study the gene expression changes caused by the induction of woven and
lamellar bone. Both the timing and magnitude of gene expression changes were different
between the formation of woven and lamellar bone. After damaging loading, there was a
significant upregulation of genes associated with cell proliferation and angiogenesis followed by a
robust upregulation of osteogenic genes. In contrast, non-damaging loading did not induce large
changes in gene expression at any timepoint. An increase in vascular support precedes woven,
but not lamellar bone formation. The early differences in magnitude of angiogenic and
osteogenic gene expression between woven and lamellar bone are reflected in the physical
changes in vasculature and bone formation at 3 and 10 days, respectively.
Expanding our subset of target genes using a whole genome microarray allowed us to
simultaneously measure the expression of thousands of genes. There was differential expression
of hundreds of genes 1 hr after loading between woven and lamellar bone formation, and
thousands of genes on days 1 and 3. Because we did not pre-select target genes for the
microarray, we were able to expand our previous findings on angiogenesis and strengthen our
understanding of the role of osteogenic pathways. In addition, use of the microarray brought to
light many inflammatory factors not previously investigated in our model. After confirming select
microarray genes using qRT-PCR we concluded that woven bone formation required a significant
early inflammation response prior to an increase in angiogenic and osteogenic gene expression.
Additionally, mechanisms for the attenuation of the inflammatory, angiogenic and osteogenic
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responses were also active at various timepoints. Analysis of the microarray demonstrated the
complexities in gene expression that are required to promote the sequential events of bone
formation.
Our data suggested that angiogenesis was critical to woven bone formation. However,
our attempts to show that an inhibition of angiogenesis led to a reduction in woven bone
formation were unsuccessful. We had moderate success using a widely published angiogenic
inhibitor, TNP-470. In spite of its predicted inhibitory affects, we saw no change in vasculature
following administration of TNP-470. Despite this, TNP-470 impaired woven bone formation.
Moreover, administration of vascular inhibitors SU5416 and YC-1 did not decrease bone
formation (although their effect on the vasculature was not investigated). These studies made it
clear that in order to determine the role of angiogenesis we need to validate the delivery of the
drug to the periosteal midshaft of the ulna and ensure that the drug is affecting its target.
Finally, as studies had shown that the magnitude of applied strain was not the key
regulator of woven bone formation, we sought to separate the effects of bone damage from
dynamic strain. We assessed damage following creep loading and compared those results to
historical fatigue loading groups. Using discrete damage-matched levels of forelimb loading we
were able to stimulate a dose-response in woven bone formation following creep loading.
Because of the absence of dynamic strain in creep loading, our findings demonstrate that bone
damage triggers the woven bone response. We also demonstrated that after creep or fatigue
loading, the woven bone response leads to a functional repair of whole-bone strength.
In summary, using the rat forelimb loading model we have advanced our understanding
of the formation of woven and lamellar bone. Ulnar damage is a key trigger for woven bone
formation, not dynamic strain. In contrast, lamellar bone formation does not require bone
damage. The molecular response varies between the two types of bone formation. Prior to
woven bone formation there is a large inflammation response that is not present prior to lamellar
bone formation. An increase in vascularity precedes woven, but not lamellar bone formation. In
addition, both the angiogenic and osteogenic responses are greater for woven bone formation
than for lamellar bone formation.
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Future Directions
The role of angiogenesis needs to be investigated further to determine the link between

vascular changes and bone formation. We hypothesized that woven bone formation is
dependent on increases in angiogenesis. Microarray results demonstrated that factors involved
in vessel dilation were upregulated in response to damaging loading. By further characterization
of angiogenesis using this model, we will improve our understanding of the vascular role in new
bone formation. A feasible first step in this investigation would be to characterize the blood flow
following damaging and non-damaging loading. If blood flow is increased following forelimb
loading, a future angiogenic inhibition study could attempt to target both the increased blood flow
as well as new blood vessel formation.
Additionally, there are still large amounts of data available for analysis in the microarray.
One shortcoming to our analysis was that based on our stringent significance criteria, we had
very few genes that were upregulated between lamellar and control. It would be advantageous to
relax the significance criteria and determine which genes are promoting lamellar bone formation.
Finally, while the rat has been an excellent animal model for this system, forelimb loading
using mouse models can take advantage of genetically altered animals to help us understand the
difference between woven and lamellar bone formation. It would be very interesting to investigate
the bone formation response to forelimb loading, particularly in mouse models of immune
deficiency, alterations in vasculature or bone formation defects. These could be very powerful
tools to manipulate our model system without using any type of drug inhibition.
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Appendix A – Blood Vessel Quantification
A.1

Introduction
MicroCT is commonly used to image bone. Normally, on a two-dimensional cross section

of an imaged specimen, a threshold is used to segment bone from soft tissue to yield a binary
image. Typically, blood vessels are impossible to discern from the surrounding soft tissue.
However, by filling the vasculature with a radio-opaque substance (Microfil) we were able to
image the vessels in the tissue surrounding the bone. In order to calculate the vessel volume in
the tissue surrounding the bone, a modified analysis method had to be devised. Then we used
standard histological techniques to verify the location of blood vessels and to obtain quantitative
analysis of vessel number and area.

A.2

Methods

A.2.1

MicroCT Analysis
A 1.6 mm section (100 slices) of the ulna (with surrounding muscle intact) was scanned

at 16 µm resolution. On the two-dimensional images contours were drawn that outlined the ulna
on all 100 slices. Using the manufacturer’s software the bone volume was calculated (sigma 1.2,
support 2, threshold 345). Then, the ulna contour was dilated 20 pixels away from the bone
surface (Figure A.1). A three-dimensional analysis was performed again to calculate the total
volume of both the bone and surrounding vessels. To obtain the vessel volume, the total bone
volume from the small (ulna only) contour was subtracted from the larger dilated volume. Finally,
a three-dimensional reconstruction with the outer and inner contours was made (Figure A.2).
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Figure A.1. A microCT two-dimensional cross section showing the ulna, radius and surrounding
muscle tissue. The ulna and vessels were quantified inside of the green contour, while
surrounding muscle was excluded from analysis. The entire forelimb takes up most of the 16 mm
diameter of the scanning tube (shown as light gray circle).

Figure A. 2. MicroCT three-dimensional reconstructions of ulna midshaft and surrounding
vasculature. On the left-hand side is the reconstruction prior to color manipulation. The image on
the right-hand side shows the vessels in red, the bone in grey and the background as white.

A.2.2

Histological Analysis
After scanning with microCT, the forelimbs were decalcified for three weeks using EDTA.

The bones (and surrounding tissue) were embedded in paraffin and sections 5 μm thick were cut.
Then, sections were stained using H&E to help visualize morphology (Figure A.3). Using
Bioquant software, bone area and perimeter were quantified (threshold [255,0]). Then, a larger
tissue volume was drawn intersecting the expanded periosteum and muscle cuff. The area was
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re-analyzed (threshold [135,0]; smoothing; low filter = 0) after erasing any vessels inside of the
bone. From this analysis, vessel number, vessel area, and mean vessel area were calculated for
each sample.

Figure A.3. Non-stained (left) and H&E stained (right) paraffin sections of loaded ulnae and
surrounding tissue that has been perfused with microfil. The area inside of the red contour was
analyzed for vessel number and area.

A.3

Results
Using microCT and standard histological techniques the vessels surrounding the ulna

were analyzed. There are large blood vessels on the medial side of the ulna in control and
loaded sections shown both on microCT and histologically. The specific applied thresholds (for
both microCT and histology) attempted to reflect the actual vessel and bone area. Analysis
results are in Chapters 2 and 4.

A.4

Conclusions
Vascular perfusion with microfil can be used to determine vessel volume, number and

area in the periosteum of the rat ulna. Because the blood vessels in our model were on the
periosteal surface, it permitted separation of the bone from the surrounding vasculature. If the
vasculature inside the bone needed to be quantified, a calcified bone could not have been used,
as it is impossible to separate vessels from bone using standard microCT thresholding
techniques. A standard histological section (on decalcified bone) allows a much higher resolution
image of vessels and allows a more accurate quantification of vessel number and area.
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Appendix B
B.1

Microarray Sample Setup

Introduction
Microarrays are becoming a common tool used in scientific research. A number of

papers have been written on the subject of microarray sample size. In order to ensure we were
able to obtain statistically relevant results using the smallest number of microarray’s, we did a
complete power analysis prior to beginning our experiment. Microarray variation can be classified
into three categories; array variation, non-array-technical variation and biological variation (Shih
2004). Although we have little control over array variation, we can control non-array-technical
variation, and we can investigate biological variation using pooled or non-pooled data in our array
analysis (Agrawal 2002, Kendziorski 2005). Pooling would average the data from multiple animals
onto one chip and require fewer microarrays per group, but would potentially have a higher
animal-to-animal variability that could not be sorted out. Single microarrays (without pooling)
could potentially have a higher cost, as more arrays would need to be done to get the same
statistical significance.

B.2

Methods
Relevant microarray literature was surveyed to determine whether or not pooling would

be beneficial in our model. It has been shown that pooling is advantageous when biological
variability is large compared to technical variability (replicates) (Kendziorski 2005). This could
potentially hide biological variance and give false confidence concerning the data significance
(Zhang 2005). Also, it was reported that increasing the sample size did not change the accuracy
of the array beyond a certain point (Figure B.1) (Kendziorski 2005). If there is enough RNA from
each individual animal to run an array, the non-pooled design is recommended (Shih 2004).
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Figure B.1. Microarray design accuracy. (A) Using lists of fixed size, the accuracy of the
microarray was calculated. The solid lines give the average performer across 100 subsets, while
the dashed lines give the worst case performer. The top (pink) line shows the results from 6
animals on 6 separate arrays, which was higher than the yellow line (12 animals split into pools of
3 on 4 arrays). (B) In a different type of analysis, the false discovery rate (FDR) was varied and
the accuracy calculated. Each vertical tick on the FDR plot marks 100 genes identified at the
specified level of FDR. As the FDR increases, the accuracy of the animals per array converge.
(Kendziorski 2005).

We then needed to determine how many samples would be necessary for statistically
significant results. We used a power function (S) (Zhang 2005), which reads

S=

∞

⎡ −ξ Y
μ⎤
(Y)Φ
+
⎢
⎥dY .
n c +n t −2
⎣ nc + nt − 2 σ D ⎦

∫P
0

(B.1)

A detailed description of the variables in the equation can be found in (Zhang 2005). Using a
variety of user input, the formula determined statistical power (Table B.1)
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Table B.1. The variable inputs for use in the power function (Zhang 2005). The application can
be accessed at http://wads.le.ac.uk/htox/WadsSoftware/MrcStats/SCal4Poolings.jnlp.
Variable
name
Nc
Nt
R
M
var_bio
Pth
Mu
Ns
Nm

Variable description
number of pools for the control population
number of pools for the treatment population
number of biological subjects used to form a pool
number of measurements made on each pool
biological variance at individual subject level
threshold p value; or false positive rate which is sometimes
denoted by the symbol alpha
magnitude of difference between the two populations
total number of biological subjects from the two populations
total number of measurements in the experiment

Values used
4, 5 or 6
4, 5 or 6
1 or 3
1
0.05
0.00001-0.01
1
r=1: 8, 10 or 12
r=3: 24, 30 or 36

Finally, the cost considerations between pooling and non-pooling were considered. We
took into account the cost of animals (baseline cost plus housing), tissue processing and fees
associated with microarray chips and reagents.

B.3

Results
One of the main strengths of pooling samples was to obtain a certain quantity of RNA.

Since we knew exactly how much RNA to expect from both loaded and normal samples (based
on our gene expression study in Chapter 2) there was no question that each animal would
provide enough RNA for a single microarray. Our power study showed us that using a nonpooled microarray with a sample size of 6 or greater would yield statistically significant results at
a variety of p-values (Table B.2). Our cost analysis was $12,330 for non-pooled samples and
$15,630 for pooled samples. Because the rat chips we were using came in sets of 12 arrays, in
order to get the most arrays done (and therefore be most efficient) we decided to use a total of 7
arrays per loading protocol and timepoint along with 6 normal controls.

99

Table B.2. The results of power analysis for select p-values and array numbers. We looked at
both non-pooling and pooling scenarios of 6 and 4 arrays, respectively.

B.4

P-value

S (no pooling; 6 arrays)

S (pooling; 4 arrays)

P = 0.005

0.998

0.994

P = 0.001

0.980

0.900

P = 0.0005

0.953

0.796

Conclusions
A microarray requires a significant investment in time and resources. Considerations are

taken based on published data, the volume of tissue processed for each rat ulna and the overall
cost of the microarray experiment. A thorough look into pooled vs. non-pooled samples prior to
microarray completion gave us a better indication of how to get the most statistically relevant
information out of our experimental model. We found that using non-pooled distribution would
actually lower cost without reducing the power of our results. A pooled experimental design does
not necessarily guarantee savings of cost unless the subject cost is low relative to the array cost
(Shih 2004). Based on all of the above data, we decided to do a non-pooled microarray study.
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